{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:56:24Z","timestamp":1791608184262,"version":"4.3.4"},"reference-count":290,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The Scientific Research Promotion Program of \u201cXinglin Scholars\u201d in 2022","award":["NO.XKTD2022005"],"award-info":[{"award-number":["NO.XKTD2022005"]}]},{"name":"The Scientific Research Promotion Program of \u201cXinglin Scholars\u201d in 2022","award":["NO.XKTD2022005"],"award-info":[{"award-number":["NO.XKTD2022005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-025-03687-z","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T04:33:58Z","timestamp":1756355638000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Exploring the role of oxidative stress in retinal vein occlusion: an updated and comprehensive review on the pathophysiology and treatment perspectives"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5676-4681","authenticated-orcid":false,"given":"Jiaqi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2874-5800","authenticated-orcid":false,"given":"Xuejun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5799-645X","authenticated-orcid":false,"given":"Ya","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,28]]},"reference":[{"key":"3687_CR1","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1111\/j.1538-7836.2010.03909.x","volume":"8","author":"M Rehak","year":"2010","unstructured":"Rehak M, Wiedemann P (2010) Retinal vein thrombosis: pathogenesis and management. J Thromb Haemost 8:1886\u20131894. https:\/\/doi.org\/10.1111\/j.1538-7836.2010.03909.x","journal-title":"J Thromb Haemost"},{"key":"3687_CR2","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1097\/HJH.0000000000002057","volume":"37","author":"KA Ponto","year":"2019","unstructured":"Ponto KA, Scharrer I, Binder H, Korb C, Rosner AK, Ehlers TO, Rieser N, Gr\u00fcbel NC, Rossmann H, Wild PS, Feltgen N, Pfeiffer N, Mirshahi A (2019) Hypertension and multiple cardiovascular risk factors increase the risk for retinal vein occlusions: results from the Gutenberg retinal vein occlusion study. J Hypertens 37:1372\u20131383. https:\/\/doi.org\/10.1097\/HJH.0000000000002057","journal-title":"J Hypertens"},{"key":"3687_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0252530","volume":"16","author":"HM Kang","year":"2021","unstructured":"Kang HM, Hasanuzzaman M, Kim SW, Koh HJ, Lee SC (2021) Significant elevation of aqueous endothelin-1 in central retinal vein occlusion. PLoS One 16:e0252530. https:\/\/doi.org\/10.1371\/journal.pone.0252530","journal-title":"PLoS One"},{"key":"3687_CR4","doi-asserted-by":"publisher","first-page":"328","DOI":"10.2174\/1573399811666150615151324","volume":"17","author":"C Campa","year":"2016","unstructured":"Campa C, Alivernini G, Bolletta E, Battaglia Parodi M, Perri P (2016) Anti-VEGF therapy for retinal vein occlusions. CDT 17:328\u2013336. https:\/\/doi.org\/10.2174\/1573399811666150615151324","journal-title":"CDT"},{"key":"3687_CR5","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/APO.0000000000000598","volume":"12","author":"F Romano","year":"2023","unstructured":"Romano F, Lamanna F, Gabrielle PH, Teo KYC, Battaglia Parodi M, Iacono P, Fraser-Bell S, Cornish EE, Nassisi M, Viola F, Agarwal A, Samanta A, Chhablani J, Staurenghi G, Invernizzi A (2023) Update on retinal vein occlusion. Asia Pac J Ophthalmol 12:196\u2013210. https:\/\/doi.org\/10.1097\/APO.0000000000000598","journal-title":"Asia Pac J Ophthalmol"},{"key":"3687_CR6","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.ajcnut.2023.07.006","volume":"118","author":"J Ren","year":"2023","unstructured":"Ren J, Ren A, Huang Z, Deng X, Jiang Z, Xue Y, Fu Z, Smith LEH, Ke M, Gong Y (2023) Metabolomic profiling of long-chain polyunsaturated fatty acid oxidation in adults with retinal vein occlusion: a case-control study. Am J Clin Nutr 118:579\u2013590. https:\/\/doi.org\/10.1016\/j.ajcnut.2023.07.006","journal-title":"Am J Clin Nutr"},{"key":"3687_CR7","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.3390\/biom10101414","volume":"10","author":"D-K Hwang","year":"2020","unstructured":"Hwang D-K, Chang Y-L, Lin T-C, Peng C-H, Chien K-H, Tsai C-Y, Chen S-J, Chen K-H, Hsu M-Y (2020) Changes in the systemic expression of sirtuin-1 and oxidative stress after intravitreal anti-vascular endothelial growth factor in patients with retinal vein occlusion. Biomolecules 10:1414. https:\/\/doi.org\/10.3390\/biom10101414","journal-title":"Biomolecules"},{"key":"3687_CR8","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1177\/1358863X20913609","volume":"25","author":"N Gouliopoulos","year":"2020","unstructured":"Gouliopoulos N, Siasos G, Moschos MM, Oikonomou E, Rouvas A, Bletsa E, Stampouloglou P, Siasou G, Paraskevopoulos T, Vlasis K, Marinos G, Tousoulis D (2020) Endothelial dysfunction and impaired arterial wall properties in patients with retinal vein occlusion. Vasc Med 25:302\u2013308. https:\/\/doi.org\/10.1177\/1358863X20913609","journal-title":"Vasc Med"},{"key":"3687_CR9","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S1350-9462(00)00028-8","volume":"20","author":"J Flammer","year":"2001","unstructured":"Flammer J, Pache M, Resink T (2001) Vasospasm, its role in the pathogenesis of diseases with particular reference to the eye. Prog Retin Eye Res 20:319\u2013349. https:\/\/doi.org\/10.1016\/S1350-9462(00)00028-8","journal-title":"Prog Retin Eye Res"},{"key":"3687_CR10","doi-asserted-by":"publisher","DOI":"10.4178\/epih.e2023035","volume":"45","author":"J Yoo","year":"2023","unstructured":"Yoo J, Shin JY, Jeon J, Kim J (2023) Impact of statin treatment on cardiovascular events in patients with retinal vein occlusion: a nested case-control study in Korea. Epidemiol Health 45:e2023035. https:\/\/doi.org\/10.4178\/epih.e2023035","journal-title":"Epidemiol Health"},{"key":"3687_CR11","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1097\/IAE.0b013e3182870c15","volume":"33","author":"A Jaulim","year":"2013","unstructured":"Jaulim A, Ahmed B, Khanam T, Chatziralli IP (2013) Branch retinal vein occlusion. Retina 33:901\u2013910. https:\/\/doi.org\/10.1097\/IAE.0b013e3182870c15","journal-title":"Retina"},{"key":"3687_CR12","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1177\/1120672120960333","volume":"31","author":"TY Chen","year":"2021","unstructured":"Chen TY, Uppuluri A, Zarbin MA, Bhagat N (2021) Risk factors for central retinal vein occlusion in young adults. Eur J Ophthalmol 31:2546\u20132555. https:\/\/doi.org\/10.1177\/1120672120960333","journal-title":"Eur J Ophthalmol"},{"key":"3687_CR13","doi-asserted-by":"publisher","first-page":"RA138","DOI":"10.12659\/MSM.883260","volume":"18","author":"B Terelak-Borys","year":"2012","unstructured":"Terelak-Borys B, Skonieczna K, Grabska-Liberek I (2012) Ocular ischemic syndrome \u2013 a systematic review. Med Sci Monit 18:RA138\u2013RA144. https:\/\/doi.org\/10.12659\/MSM.883260","journal-title":"Med Sci Monit"},{"key":"3687_CR14","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1080\/14779072.2022.2112667","volume":"20","author":"M \u00d8rskov","year":"2022","unstructured":"\u00d8rskov M, Vorum H, Bjerregaard Larsen T, Vestergaard N, Lip GYH, Bek T, Skj\u00f8th F (2022) A review of risk factors for retinal vein occlusions. Expert Rev Cardiovasc Ther 20:761\u2013772. https:\/\/doi.org\/10.1080\/14779072.2022.2112667","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"3687_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s40885-023-00258-1","volume":"29","author":"H-L Kim","year":"2023","unstructured":"Kim H-L (2023) Arterial stiffness and hypertension. Clin Hypertens 29:31. https:\/\/doi.org\/10.1186\/s40885-023-00258-1","journal-title":"Clin Hypertens"},{"key":"3687_CR16","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1080\/08164622.2021.1964332","volume":"105","author":"Y Cui","year":"2022","unstructured":"Cui Y, Pan L, Lam T, Wen C, Do C (2022) Mechanistic links between systemic hypertension and open angle glaucoma. Clin Exp Optom 105:362\u2013371. https:\/\/doi.org\/10.1080\/08164622.2021.1964332","journal-title":"Clin Exp Optom"},{"key":"3687_CR17","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/ahg.12552","volume":"88","author":"J Zhang","year":"2024","unstructured":"Zhang J, Pan Y, Yang H, Hu S, Zheng S, He T (2024) Genetically predicted retinal vascular occlusion in relation to cardiovascular diseases: a bidirectional two-sample Mendelian randomization analysis. Ann Hum Genet 88:336\u2013348. https:\/\/doi.org\/10.1111\/ahg.12552","journal-title":"Ann Hum Genet"},{"key":"3687_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2023.100388","volume":"3","author":"EJ Bilton","year":"2023","unstructured":"Bilton EJ, Guggenheim EJ, Baranyi B, Radovanovic C, Williams RL, Bradlow W, Denniston AK, Mollan SP (2023) A datasheet for the INSIGHT University Hospitals Birmingham retinal vein occlusion data set. Ophthalmol Sci 3:100388. https:\/\/doi.org\/10.1016\/j.xops.2023.100388","journal-title":"Ophthalmol Sci"},{"key":"3687_CR19","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.medcli.2024.01.048","volume":"163","author":"M Larrousse Morell\u00f3n","year":"2024","unstructured":"Larrousse Morell\u00f3n M, L\u00f3pez Loureiro Y, Ruiz Bilbao S (2024) Oclusi\u00f3n venosa de retina y su asociaci\u00f3n con la enfermedad vascular ateroscler\u00f3tica. Med Clin 163:199\u2013207. https:\/\/doi.org\/10.1016\/j.medcli.2024.01.048","journal-title":"Med Clin"},{"issue":"25","key":"3687_CR20","doi-asserted-by":"publisher","first-page":"00126","DOI":"10.1016\/j.ophtha.2025.02.007","volume":"S0161\u20136420","author":"AM Voigt","year":"2025","unstructured":"Voigt AM, Elbaz H, B\u00f6hm EW, Wild PS, Lackner KJ, Beutel ME, Schmidtmann I, T\u00fcscher O, Schattenberg JM, Konstantinides SV, Pfeiffer N, Peto T, Schuster AK (2025) Incidence of retinal vein occlusion and its association with mortality. Ophthalmology S0161\u20136420(25):00126\u20135. https:\/\/doi.org\/10.1016\/j.ophtha.2025.02.007","journal-title":"Ophthalmology"},{"key":"3687_CR21","doi-asserted-by":"publisher","first-page":"76","DOI":"10.4274\/tjo.galenos.2024.66367","volume":"54","author":"\u015e G\u00f6n\u00fcl","year":"2024","unstructured":"G\u00f6n\u00fcl \u015e, Eker S (2024) Assessment of serum atherogenic indices and insulin resistance in retinal vein occlusion. Turk J Ophthalmol 54:76\u201382. https:\/\/doi.org\/10.4274\/tjo.galenos.2024.66367","journal-title":"Turk J Ophthalmol"},{"key":"3687_CR22","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12886-020-01405-0","volume":"20","author":"L Chen","year":"2020","unstructured":"Chen L, Yuan M, Sun L, Wang Y, Chen Y (2020) Evaluation of microvascular network with optical coherence tomography angiography (OCTA) in branch retinal vein occlusion (BRVO). BMC Ophthalmol 20:154. https:\/\/doi.org\/10.1186\/s12886-020-01405-0","journal-title":"BMC Ophthalmol"},{"key":"3687_CR23","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s10792-021-02015-5","volume":"42","author":"L Fan","year":"2022","unstructured":"Fan L, Zhu Y, Liao R (2022) Evaluation of macular microvasculature and foveal avascular zone in patients with retinal vein occlusion using optical coherence tomography angiography. Int Ophthalmol 42:211\u2013218. https:\/\/doi.org\/10.1007\/s10792-021-02015-5","journal-title":"Int Ophthalmol"},{"key":"3687_CR24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1167\/iovs.65.2.6","volume":"65","author":"X Zhao","year":"2024","unstructured":"Zhao X, Zhao Q, Wang C, Meng L, Cheng S, Gu X, Sadda SR, Chen Y (2024) Central and peripheral changes in retinal vein occlusion and fellow eyes in ultra-widefield optical coherence tomography angiography. Invest Ophthalmol Vis Sci 65:6. https:\/\/doi.org\/10.1167\/iovs.65.2.6","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3687_CR25","doi-asserted-by":"publisher","first-page":"251584142210900","DOI":"10.1177\/25158414221090092","volume":"14","author":"CU Atilgan","year":"2022","unstructured":"Atilgan CU, Goker YS, Hondur G, Kosekahya P, Kocer AM, Citirik M (2022) Evaluation of the radial peripapillary capillary density in unilateral branch retinal vein occlusion and the unaffected fellow eyes. Ophthalmol Eye Dis 14:251584142210900. https:\/\/doi.org\/10.1177\/25158414221090092","journal-title":"Ophthalmol Eye Dis"},{"key":"3687_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fopht.2022.869843","volume":"2","author":"Y Wang","year":"2022","unstructured":"Wang Y, Wang S, Wang S, Ding M, Zhang M, Tang J, Deng A (2022) Chorioretinal venous anastomosis for non-ischemic retinal vein occlusion. Front Ophthalmol 2:869843. https:\/\/doi.org\/10.3389\/fopht.2022.869843","journal-title":"Front Ophthalmol"},{"key":"3687_CR27","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/IAE.0000000000003281","volume":"42","author":"YJ Park","year":"2022","unstructured":"Park YJ, Kim J, Lee EJ, Park KH (2022) Peripapillary microvasculature of the retina and choriocapillaris in uninvolved fellow eyes of unilateral retinal vein occlusion patients. Retina 42:159\u2013167. https:\/\/doi.org\/10.1097\/IAE.0000000000003281","journal-title":"Retina"},{"key":"3687_CR28","doi-asserted-by":"publisher","DOI":"10.31083\/j.fbl2909319","volume":"29","author":"D Rusciano","year":"2024","unstructured":"Rusciano D, Bagnoli P (2024) Oxygen, the paradox of life and the eye. Front Biosci (Landmark Ed) 29:319. https:\/\/doi.org\/10.31083\/j.fbl2909319","journal-title":"Front Biosci (Landmark Ed)"},{"key":"3687_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241310776","volume":"24","author":"Y Markitantova","year":"2023","unstructured":"Markitantova Y, Simirskii V (2023) Endogenous and exogenous regulation of redox homeostasis in retinal pigment epithelium cells: an updated antioxidant perspective. IJMS 24:10776. https:\/\/doi.org\/10.3390\/ijms241310776","journal-title":"IJMS"},{"key":"3687_CR30","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1080\/15384101.2023.2215084","volume":"22","author":"C Guo","year":"2023","unstructured":"Guo C, Ning X, Zhang J, Zhang C, Wang J, Su L, Han J, Ma N (2023) Ultraviolet B radiation induces oxidative stress and apoptosis in human lens epithelium cells by activating NF-\u03baB signaling to down-regulate sodium vitamin C transporter 2 (SVCT2) expression. Cell Cycle 22:1450\u20131462. https:\/\/doi.org\/10.1080\/15384101.2023.2215084","journal-title":"Cell Cycle"},{"key":"3687_CR31","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3390\/biomedicines11020292","volume":"11","author":"A Dammak","year":"2023","unstructured":"Dammak A, Pastrana C, Martin-Gil A, Carpena-Torres C, Peral Cerda A, Simovart M, Alarma P, Huete-Toral F, Carracedo G (2023) Oxidative stress in the anterior ocular diseases: diagnostic and treatment. Biomedicines 11:292. https:\/\/doi.org\/10.3390\/biomedicines11020292","journal-title":"Biomedicines"},{"key":"3687_CR32","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.3390\/antiox10121948","volume":"10","author":"EY-C Kang","year":"2021","unstructured":"Kang EY-C, Liu P-K, Wen Y-T, Quinn PMJ, Levi SR, Wang N-K, Tsai R-K (2021) Role of oxidative stress in ocular diseases associated with retinal ganglion cells degeneration. Antioxidants 10:1948. https:\/\/doi.org\/10.3390\/antiox10121948","journal-title":"Antioxidants"},{"key":"3687_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031255","volume":"23","author":"Y-J Hsueh","year":"2022","unstructured":"Hsueh Y-J, Chen Y-N, Tsao Y-T, Cheng C-M, Wu W-C, Chen H-C (2022) The pathomechanism, antioxidant biomarkers, and treatment of oxidative stress-related eye diseases. IJMS 23:1255. https:\/\/doi.org\/10.3390\/ijms23031255","journal-title":"IJMS"},{"key":"3687_CR34","doi-asserted-by":"publisher","first-page":"544","DOI":"10.17179\/excli2022-4663","volume":"21","author":"S Taurone","year":"2022","unstructured":"Taurone S, Ralli M, Artico M, Madia VN, Scarpa S, Nottola SA, Maconi A, Betti M, Familiari P, Nebbioso M, Costi R, Micera A (2022) Oxidative stress and visual system: a review. EXCLI J 21:544\u2013553. https:\/\/doi.org\/10.17179\/excli2022-4663","journal-title":"EXCLI J"},{"key":"3687_CR35","doi-asserted-by":"publisher","first-page":"1069449","DOI":"10.3389\/fmed.2022.1069449","volume":"9","author":"EW B\u00f6hm","year":"2022","unstructured":"B\u00f6hm EW, Pfeiffer N, Wagner FM, Gericke A (2022) Methods to measure blood flow and vascular reactivity in the retina. Front Med 9:1069449. https:\/\/doi.org\/10.3389\/fmed.2022.1069449","journal-title":"Front Med"},{"key":"3687_CR36","doi-asserted-by":"publisher","first-page":"668","DOI":"10.3390\/nu10060668","volume":"10","author":"SC Sacc\u00e0","year":"2018","unstructured":"Sacc\u00e0 SC, Cutolo CA, Ferrari D, Corazza P, Traverso CE (2018) The eye, oxidative damage and polyunsaturated fatty acids. Nutrients 10:668. https:\/\/doi.org\/10.3390\/nu10060668","journal-title":"Nutrients"},{"key":"3687_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102967","volume":"68","author":"EW B\u00f6hm","year":"2023","unstructured":"B\u00f6hm EW, Buonfiglio F, Voigt AM, Bachmann P, Safi T, Pfeiffer N, Gericke A (2023) Oxidative stress in the eye and its role in the pathophysiology of ocular diseases. Redox Biol 68:102967. https:\/\/doi.org\/10.1016\/j.redox.2023.102967","journal-title":"Redox Biol"},{"key":"3687_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9080761","volume":"9","author":"Y Ruan","year":"2020","unstructured":"Ruan Y, Jiang S, Musayeva A, Gericke A (2020) Oxidative stress and vascular dysfunction in the retina: therapeutic strategies. Antioxidants 9:761. https:\/\/doi.org\/10.3390\/antiox9080761","journal-title":"Antioxidants"},{"key":"3687_CR39","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/jemt.24284","volume":"86","author":"G Astolfi","year":"2023","unstructured":"Astolfi G, Ciavarella C, Valente S, Coslovi C, Iannetta D, Fontana L, Pasquinelli G, Versura P (2023) Human glial m\u00fcller and umbilical vein endothelial cell coculture as an in vitro model to investigate retinal oxidative damage. A morphological and molecular assessment. Microsc Res Tech 86:439\u2013451. https:\/\/doi.org\/10.1002\/jemt.24284","journal-title":"Microsc Res Tech"},{"key":"3687_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/cells10123575","volume":"10","author":"AM Mueller-Buehl","year":"2021","unstructured":"Mueller-Buehl AM, Buehner T, Pfarrer C, Deppe L, Peters L, Dick BH, Joachim SC (2021) Hypoxic processes induce complement activation via classical pathway in porcine neuroretinas. Cells 10:3575. https:\/\/doi.org\/10.3390\/cells10123575","journal-title":"Cells"},{"key":"3687_CR41","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1167\/iovs.17-23376","volume":"59","author":"C Karaca","year":"2018","unstructured":"Karaca C, Karaca Z (2018) Beyond hyperglycemia, evidence for retinal neurodegeneration in metabolic syndrome. Invest Ophthalmol Vis Sci 59:1360. https:\/\/doi.org\/10.1167\/iovs.17-23376","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3687_CR42","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ajpath.2023.11.004","volume":"194","author":"L Tang","year":"2024","unstructured":"Tang L, Zhang H, Liao Y, Zhou S, Yang Y, Zhang M, Guo Y, Xie T, Chen S, Ouyang W, Lin X, Wang S, Huang C, Zhang M, Zhuang J, Zhao J, Zhang R, Zhang C, Jin Z, Hu J, Liu Z (2024) Chronic sleep deprivation impairs visual functions via oxidative damage in mice. Am J Pathol 194:307\u2013320. https:\/\/doi.org\/10.1016\/j.ajpath.2023.11.004","journal-title":"Am J Pathol"},{"key":"3687_CR43","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsac047","volume":"45","author":"L Wang","year":"2022","unstructured":"Wang L, Aton SJ (2022) Perspective \u2013 ultrastructural analyses reflect the effects of sleep and sleep loss on neuronal cell biology. Sleep 45:zsac047. https:\/\/doi.org\/10.1093\/sleep\/zsac047","journal-title":"Sleep"},{"key":"3687_CR44","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.14336\/AD.2024.0124","volume":"16","author":"F Buonfiglio","year":"2024","unstructured":"Buonfiglio F, Korb CA, Stoffelns B, Pfeiffer N, Gericke A (2024) Recent advances in our understanding of age-related macular degeneration: mitochondrial dysfunction, redox signaling, and the complement system. Aging Dis 16:1535\u20131575. https:\/\/doi.org\/10.14336\/AD.2024.0124","journal-title":"Aging Dis"},{"key":"3687_CR45","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2147\/EB.S9078","volume":"2","author":"M Wong-Riley","year":"2010","unstructured":"Wong-Riley M (2010) Energy metabolism of the visual system. Eye Brain 2:99. https:\/\/doi.org\/10.2147\/EB.S9078","journal-title":"Eye Brain"},{"key":"3687_CR46","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1042\/CS20171246","volume":"131","author":"L Ung","year":"2017","unstructured":"Ung L, Pattamatta U, Carnt N, Wilkinson-Berka JL, Liew G, White AJR (2017) Oxidative stress and reactive oxygen species: a review of their role in ocular disease. Clin Sci (Lond) 131:2865\u20132883. https:\/\/doi.org\/10.1042\/CS20171246","journal-title":"Clin Sci (Lond)"},{"key":"3687_CR47","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s11481-014-9531-7","volume":"9","author":"S Ramakrishnan","year":"2014","unstructured":"Ramakrishnan S, Anand V, Roy S (2014) Vascular endothelial growth factor signaling in hypoxia and inflammation. J Neuroimmune Pharmacol 9:142\u2013160. https:\/\/doi.org\/10.1007\/s11481-014-9531-7","journal-title":"J Neuroimmune Pharmacol"},{"key":"3687_CR48","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.exer.2018.09.014","volume":"178","author":"M Inada","year":"2019","unstructured":"Inada M, Taguchi M, Harimoto K, Karasawa Y, Takeuchi M, Ito M (2019) Protective effects of dexamethasone on hypoxia-induced retinal edema in a mouse model. Exp Eye Res 178:82\u201390. https:\/\/doi.org\/10.1016\/j.exer.2018.09.014","journal-title":"Exp Eye Res"},{"key":"3687_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-47721-5","volume":"13","author":"A Neiteler","year":"2023","unstructured":"Neiteler A, Palakkan AA, Gallagher KM, Ross JA (2023) Oxidative stress and docosahexaenoic acid injury lead to increased necroptosis and ferroptosis in retinal pigment epithelium. Sci Rep 13:21143. https:\/\/doi.org\/10.1038\/s41598-023-47721-5","journal-title":"Sci Rep"},{"key":"3687_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/7836828","volume":"2022","author":"J Wang","year":"2022","unstructured":"Wang J, Li M, Geng Z, Khattak S, Ji X, Wu D, Dang Y (2022) Role of oxidative stress in retinal disease and the early intervention strategies: a review. Oxid Med Cell Longev 2022:1\u201313. https:\/\/doi.org\/10.1155\/2022\/7836828","journal-title":"Oxid Med Cell Longev"},{"key":"3687_CR51","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.10136","volume":"8","author":"H Zou","year":"2020","unstructured":"Zou H, Shan C, Ma L, Liu J, Yang N, Zhao J (2020) Polarity and epithelial-mesenchymal transition of retinal pigment epithelial cells in proliferative vitreoretinopathy. PeerJ 8:e10136. https:\/\/doi.org\/10.7717\/peerj.10136","journal-title":"PeerJ"},{"key":"3687_CR52","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3389\/fimmu.2020.00574","volume":"11","author":"JA Matsubara","year":"2020","unstructured":"Matsubara JA, Tian Y, Cui JZ, Zeglinski MR, Hiroyasu S, Turner CT, Granville DJ (2020) Retinal distribution and extracellular activity of granzyme B: a serine protease that degrades retinal pigment epithelial tight junctions and extracellular matrix proteins. Front Immunol 11:574. https:\/\/doi.org\/10.3389\/fimmu.2020.00574","journal-title":"Front Immunol"},{"key":"3687_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112193","volume":"134","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Yao Y, Yang J, Zhou B, Zhu Y (2024) Inhibiting the SARM1-NAD+ axis reduces oxidative stress-induced damage to retinal and nerve cells. Int Immunopharmacol 134:112193. https:\/\/doi.org\/10.1016\/j.intimp.2024.112193","journal-title":"Int Immunopharmacol"},{"key":"3687_CR54","doi-asserted-by":"publisher","first-page":"8705","DOI":"10.1038\/s41598-022-12770-9","volume":"12","author":"L Gu","year":"2022","unstructured":"Gu L, Kwong JM, Caprioli J, Piri N (2022) DNA and RNA oxidative damage in the retina is associated with ganglion cell mitochondria. Sci Rep 12:8705. https:\/\/doi.org\/10.1038\/s41598-022-12770-9","journal-title":"Sci Rep"},{"key":"3687_CR55","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1089\/ars.2012.5149","volume":"20","author":"M Mittal","year":"2014","unstructured":"Mittal M, Siddiqui MR, Tran K, Reddy SP, Malik AB (2014) Reactive oxygen species in inflammation and tissue injury. Antioxid Redox Signal 20:1126\u20131167. https:\/\/doi.org\/10.1089\/ars.2012.5149","journal-title":"Antioxid Redox Signal"},{"key":"3687_CR56","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1177\/1120672120919337","volume":"30","author":"A Murali","year":"2020","unstructured":"Murali A, Krishnakumar S, Subramanian A, Parameswaran S (2020) Bruch\u2019s membrane pathology: a mechanistic perspective. Eur J Ophthalmol 30:1195\u20131206. https:\/\/doi.org\/10.1177\/1120672120919337","journal-title":"Eur J Ophthalmol"},{"key":"3687_CR57","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.freeradbiomed.2019.11.018","volume":"146","author":"SS Eamegdool","year":"2020","unstructured":"Eamegdool SS, Sitiwin EI, Cioanca AV, Madigan MC (2020) Extracellular matrix and oxidative stress regulate human retinal pigment epithelium growth. Free Radic Biol Med 146:357\u2013371. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2019.11.018","journal-title":"Free Radic Biol Med"},{"key":"3687_CR58","doi-asserted-by":"publisher","first-page":"14175","DOI":"10.1038\/s41598-021-93708-5","volume":"11","author":"R Choudhury","year":"2021","unstructured":"Choudhury R, Bayatti N, Scharff R, Szula E, Tilakaratna V, Udsen MS, McHarg S, Askari JA, Humphries MJ, Bishop PN, Clark SJ (2021) FHL-1 interacts with human RPE cells through the \u03b15\u03b21 integrin and confers protection against oxidative stress. Sci Rep 11:14175. https:\/\/doi.org\/10.1038\/s41598-021-93708-5","journal-title":"Sci Rep"},{"key":"3687_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2021.108899","volume":"215","author":"AL Engel","year":"2022","unstructured":"Engel AL, Wang Y, Khuu TH, Worrall E, Manson MA, Lim RR, Knight K, Yanagida A, Qi JH, Ramakrishnan A, Weleber RG, Klein ML, Wilson DJ, Anand-Apte B, Hurley JB, Du J, Chao JR (2022) Extracellular matrix dysfunction in Sorsby patient-derived retinal pigment epithelium. Exp Eye Res 215:108899. https:\/\/doi.org\/10.1016\/j.exer.2021.108899","journal-title":"Exp Eye Res"},{"key":"3687_CR60","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s11658-021-00283-8","volume":"26","author":"M Zhao","year":"2021","unstructured":"Zhao M, Wang S, Zuo A, Zhang J, Wen W, Jiang W, Chen H, Liang D, Sun J, Wang M (2021) HIF-1\u03b1\/JMJD1A signaling regulates inflammation and oxidative stress following hyperglycemia and hypoxia-induced vascular cell injury. Cell Mol Biol Lett 26:40. https:\/\/doi.org\/10.1186\/s11658-021-00283-8","journal-title":"Cell Mol Biol Lett"},{"key":"3687_CR61","doi-asserted-by":"publisher","first-page":"712","DOI":"10.3390\/genes15060712","volume":"15","author":"A Ragkousis","year":"2024","unstructured":"Ragkousis A, Kazantzis D, Georgalas I, Theodossiadis P, Kroupis C, Chatziralli I (2024) PON1, APOE and SDF-1 gene polymorphisms and risk of retinal vein occlusion: a case-control study. Genes 15:712. https:\/\/doi.org\/10.3390\/genes15060712","journal-title":"Genes"},{"key":"3687_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2020.108255","volume":"201","author":"TCW Chan","year":"2020","unstructured":"Chan TCW, Wilkinson Berka JL, Deliyanti D, Hunter D, Fung A, Liew G, White A (2020) The role of reactive oxygen species in the pathogenesis and treatment of retinal diseases. Exp Eye Res 201:108255. https:\/\/doi.org\/10.1016\/j.exer.2020.108255","journal-title":"Exp Eye Res"},{"key":"3687_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2020.100858","volume":"79","author":"K Kaarniranta","year":"2020","unstructured":"Kaarniranta K, Uusitalo H, Blasiak J, Felszeghy S, Kannan R, Kauppinen A, Salminen A, Sinha D, Ferrington D (2020) Mechanisms of mitochondrial dysfunction and their impact on age-related macular degeneration. Prog Retin Eye Res 79:100858. https:\/\/doi.org\/10.1016\/j.preteyeres.2020.100858","journal-title":"Prog Retin Eye Res"},{"key":"3687_CR64","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1111\/aos.13152","volume":"95","author":"S Rezar-Dreindl","year":"2017","unstructured":"Rezar-Dreindl S, Eibenberger K, Pollreisz A, B\u00fchl W, Georgopoulos M, Krall C, Dunav\u00f6lgyi R, Weigert G, Kroh M, Schmidt-Erfurth U, Sacu S (2017) Effect of intravitreal dexamethasone implant on intra-ocular cytokines and chemokines in eyes with retinal vein occlusion. Acta Ophthalmol 95:e119\u2013e127. https:\/\/doi.org\/10.1111\/aos.13152","journal-title":"Acta Ophthalmol"},{"key":"3687_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2019.107902","volume":"191","author":"I Rana","year":"2020","unstructured":"Rana I, Suphapimol V, Jerome JR, Talia DM, Deliyanti D, Wilkinson-Berka JL (2020) Angiotensin II and aldosterone activate retinal microglia. Exp Eye Res 191:107902. https:\/\/doi.org\/10.1016\/j.exer.2019.107902","journal-title":"Exp Eye Res"},{"key":"3687_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.910600","volume":"9","author":"Y Tang","year":"2022","unstructured":"Tang Y, Cheng Y, Wang S, Wang Y, Liu P, Wu H (2022) The development of risk factors and cytokines in retinal vein occlusion. Front Med 9:910600. https:\/\/doi.org\/10.3389\/fmed.2022.910600","journal-title":"Front Med"},{"key":"3687_CR67","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/s41433-022-02007-4","volume":"36","author":"L Nicholson","year":"2022","unstructured":"Nicholson L, Talks SJ, Amoaku W, Talks K, Sivaprasad S (2022) Retinal vein occlusion (RVO) guideline: executive summary. Eye 36:909\u2013912. https:\/\/doi.org\/10.1038\/s41433-022-02007-4","journal-title":"Eye"},{"key":"3687_CR68","doi-asserted-by":"publisher","first-page":"24100","DOI":"10.1073\/pnas.1914143116","volume":"116","author":"AP Voigt","year":"2019","unstructured":"Voigt AP, Mulfaul K, Mullin NK, Flamme-Wiese MJ, Giacalone JC, Stone EM, Tucker BA, Scheetz TE, Mullins RF (2019) Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration. Proc Natl Acad Sci USA 116:24100\u201324107. https:\/\/doi.org\/10.1073\/pnas.1914143116","journal-title":"Proc Natl Acad Sci USA"},{"key":"3687_CR69","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1097\/IAE.0000000000002434","volume":"40","author":"TD Keenan","year":"2020","unstructured":"Keenan TD, Klein B, Agr\u00f3n E, Chew EY, Cukras CA, Wong WT (2020) Choroidal thickness and vascularity vary with disease severity and subretinal drusenoid deposit presence in nonadvanced age-related macular degeneration. Retina 40:632\u2013642. https:\/\/doi.org\/10.1097\/IAE.0000000000002434","journal-title":"Retina"},{"key":"3687_CR70","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1007\/s00417-002-0568-6","volume":"240","author":"S Hoffmann","year":"2002","unstructured":"Hoffmann S, Friedrichs U, Eichler W, Rosenthal A, Wiedemann P (2002) Advanced glycation end products induce choroidal endothelial cell proliferation, matrix metalloproteinase-2 and VEGF upregulation in vitro. Graefes Arch Clin Exp Ophthalmol 240:996\u20131002. https:\/\/doi.org\/10.1007\/s00417-002-0568-6","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3687_CR71","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.2119\/molmed.2015.00067","volume":"21","author":"S Yamagishi","year":"2015","unstructured":"Yamagishi S, Nakamura N, Suematsu M, Kaseda K, Matsui T (2015) Advanced glycation end products: a molecular target for vascular complications in diabetes. Mol Med 21:S32\u2013S40. https:\/\/doi.org\/10.2119\/molmed.2015.00067","journal-title":"Mol Med"},{"key":"3687_CR72","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1097\/IAE.0000000000000586","volume":"35","author":"A Pinhas","year":"2015","unstructured":"Pinhas A, Dubow M, Shah N, Cheang E, Liu CL, Razeen M, Gan A, Weitz R, Sulai YN, Chui TY, Dubra A, Rosen RB (2015) Fellow eye changes in patients with nonischemic central retinal vein occlusion: assessment of perfused foveal microvascular density and identification of nonperfused capillaries. Retina 35:2028\u20132036. https:\/\/doi.org\/10.1097\/IAE.0000000000000586","journal-title":"Retina"},{"key":"3687_CR73","doi-asserted-by":"publisher","DOI":"10.1017\/erm.2022.25","volume":"24","author":"A Bettiol","year":"2022","unstructured":"Bettiol A, Galora S, Argento FR, Fini E, Emmi G, Mattioli I, Bagni G, Fiorillo C, Becatti M (2022) Erythrocyte oxidative stress and thrombosis. Expert Rev Mol Med 24:e31. https:\/\/doi.org\/10.1017\/erm.2022.25","journal-title":"Expert Rev Mol Med"},{"key":"3687_CR74","doi-asserted-by":"publisher","first-page":"e290","DOI":"10.1111\/aos.13892","volume":"97","author":"K Chen","year":"2019","unstructured":"Chen K, Hsiang E, Hsu M, Chou Y, Lin T, Chang Y, Tsai C, Li T, Woung L, Chen S, Peng C, Hwang D (2019) Elevation of serum oxidative stress in patients with retina vein occlusions. Acta Ophthalmol 97:e290\u2013e295. https:\/\/doi.org\/10.1111\/aos.13892","journal-title":"Acta Ophthalmol"},{"key":"3687_CR75","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.oret.2021.05.004","volume":"6","author":"Y Li","year":"2022","unstructured":"Li Y, Hall NE, Pershing S, Hyman L, Haller JA, Lee AY, Lee CS, Chiang M, Lum F, Miller JW, Lorch A, Elze T (2022) Age, gender, and laterality of retinal vascular occlusion: a retrospective study from the IRIS\u00ae registry. Ophthalmol Retina 6:161\u2013171. https:\/\/doi.org\/10.1016\/j.oret.2021.05.004","journal-title":"Ophthalmol Retina"},{"key":"3687_CR76","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1038\/s41433-022-02163-7","volume":"37","author":"O Weinstein","year":"2023","unstructured":"Weinstein O, Kridin M, Kridin K, Mann O, Cohen AD, Zloto O (2023) The risk of retinal vein occlusion among patients with neovascular age related macular degeneration: a large-scale cohort study. Eye 37:1445\u20131450. https:\/\/doi.org\/10.1038\/s41433-022-02163-7","journal-title":"Eye"},{"key":"3687_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2020.100921","volume":"83","author":"PA Campochiaro","year":"2021","unstructured":"Campochiaro PA, Akhlaq A (2021) Sustained suppression of VEGF for treatment of retinal\/choroidal vascular diseases. Prog Retin Eye Res 83:100921. https:\/\/doi.org\/10.1016\/j.preteyeres.2020.100921","journal-title":"Prog Retin Eye Res"},{"key":"3687_CR78","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.exer.2018.09.012","volume":"181","author":"Y-S Cheng","year":"2019","unstructured":"Cheng Y-S, Linetsky M, Gu X, Ayyash N, Gardella A, Salomon RG (2019) Light-induced generation and toxicity of docosahexaenoate-derived oxidation products in retinal pigmented epithelial cells. Exp Eye Res 181:325\u2013345. https:\/\/doi.org\/10.1016\/j.exer.2018.09.012","journal-title":"Exp Eye Res"},{"key":"3687_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.626842","volume":"12","author":"M Di Gioia","year":"2021","unstructured":"Di Gioia M, Zanoni I (2021) Dooming phagocyte responses: inflammatory effects of endogenous oxidized phospholipids. Front Endocrinol 12:626842. https:\/\/doi.org\/10.3389\/fendo.2021.626842","journal-title":"Front Endocrinol"},{"key":"3687_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/5080843","volume":"2019","author":"L-J Su","year":"2019","unstructured":"Su L-J, Zhang J-H, Gomez H, Murugan R, Hong X, Xu D, Jiang F, Peng Z-Y (2019) Reactive oxygen species-induced lipid peroxidation in apoptosis, autophagy, and ferroptosis. Oxid Med Cell Longev 2019:1\u201313. https:\/\/doi.org\/10.1155\/2019\/5080843","journal-title":"Oxid Med Cell Longev"},{"key":"3687_CR81","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.exer.2007.07.021","volume":"85","author":"I-M Fang","year":"2007","unstructured":"Fang I-M, Yang C-H, Yang C-M, Chen M-S (2007) Linoleic acid-induced expression of inducible nitric oxide synthase and cyclooxygenase II via p42\/44 mitogen-activated protein kinase and nuclear factor-\u03bab pathway in retinal pigment epithelial cells. Exp Eye Res 85:667\u2013677. https:\/\/doi.org\/10.1016\/j.exer.2007.07.021","journal-title":"Exp Eye Res"},{"key":"3687_CR82","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1002\/mnfr.201400196","volume":"58","author":"I Fang","year":"2014","unstructured":"Fang I, Yang C, Yang C (2014) Docosahexaenoic acid reduces linoleic acid induced monocyte chemoattractant protein-1 expression via PPAR\u03b3 and nuclear factor-\u03baB pathway in retinal pigment epithelial cells. Mol Nutr Food Res 58:2053\u20132065. https:\/\/doi.org\/10.1002\/mnfr.201400196","journal-title":"Mol Nutr Food Res"},{"key":"3687_CR83","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22031338","volume":"22","author":"K-C Cheng","year":"2021","unstructured":"Cheng K-C, Hsu Y-T, Liu W, Huang H-L, Chen L-Y, He C-X, Sheu S-J, Chen K-J, Lee P-Y, Lin Y-H, Chiu C-C (2021) The role of oxidative stress and autophagy in blue-light-induced damage to the retinal pigment epithelium in zebrafish in vitro and in vivo. IJMS 22:1338. https:\/\/doi.org\/10.3390\/ijms22031338","journal-title":"IJMS"},{"key":"3687_CR84","doi-asserted-by":"publisher","DOI":"10.1111\/apha.13477","volume":"229","author":"N Xu","year":"2020","unstructured":"Xu N, Jiang S, Persson PB, Persson EAG, Lai EY, Patzak A (2020) Reactive oxygen species in renal vascular function. Acta Physiol 229:e13477. https:\/\/doi.org\/10.1111\/apha.13477","journal-title":"Acta Physiol"},{"key":"3687_CR85","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.935135","volume":"28","author":"J Dziedziak","year":"2022","unstructured":"Dziedziak J, Zaleska-\u017bmijewska A, Szaflik JP, Cudnoch-J\u0119drzejewska A (2022) Impact of arterial hypertension on the eye: a review of the pathogenesis, diagnostic methods, and treatment of hypertensive retinopathy. Med Sci Monit 28:e935135. https:\/\/doi.org\/10.12659\/MSM.935135","journal-title":"Med Sci Monit"},{"key":"3687_CR86","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/ceo.13119","volume":"46","author":"A Newman","year":"2018","unstructured":"Newman A, Andrew N, Casson R (2018) Review of the association between retinal microvascular characteristics and eye disease. Clin Exp Ophthalmol 46:531\u2013552. https:\/\/doi.org\/10.1111\/ceo.13119","journal-title":"Clin Exp Ophthalmol"},{"key":"3687_CR87","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1097\/HJH.0000000000001940","volume":"36","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I (2018) 2018 ESC\/ESH guidelines for the management of arterial hypertension. J Hypertens 36:1953\u20132041. https:\/\/doi.org\/10.1097\/HJH.0000000000001940","journal-title":"J Hypertens"},{"key":"3687_CR88","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/eye.1990.43","volume":"4","author":"A Bill","year":"1990","unstructured":"Bill A, Sperber GO (1990) Control of retinal and choroidal blood flow. Eye 4:319\u2013325. https:\/\/doi.org\/10.1038\/eye.1990.43","journal-title":"Eye"},{"key":"3687_CR89","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.preteyeres.2017.12.001","volume":"64","author":"A Reiner","year":"2018","unstructured":"Reiner A, Fitzgerald MEC, Del Mar N, Li C (2018) Neural control of choroidal blood flow. Prog Retin Eye Res 64:96\u2013130. https:\/\/doi.org\/10.1016\/j.preteyeres.2017.12.001","journal-title":"Prog Retin Eye Res"},{"key":"3687_CR90","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1085\/jgp.88.4.521","volume":"88","author":"RA Linsenmeier","year":"1986","unstructured":"Linsenmeier RA (1986) Effects of light and darkness on oxygen distribution and consumption in the cat retina. J Gen Physiol 88:521\u2013542. https:\/\/doi.org\/10.1085\/jgp.88.4.521","journal-title":"J Gen Physiol"},{"key":"3687_CR91","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s11906-012-0283-6","volume":"14","author":"V Katsi","year":"2012","unstructured":"Katsi V, Marketou M, Vlachopoulos C, Tousoulis D, Souretis G, Papageorgiou N, Stefanadis C, Vardas P, Kallikazaros I (2012) Impact of arterial hypertension on the eye. Curr Hypertens Rep 14:581\u2013590. https:\/\/doi.org\/10.1007\/s11906-012-0283-6","journal-title":"Curr Hypertens Rep"},{"key":"3687_CR92","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1097\/00055735-199912000-00017","volume":"10","author":"SS Hayreh","year":"1999","unstructured":"Hayreh SS (1999) Role of nocturnal arterial hypotension in the development of ocular manifestations of systemic arterial hypertension. Curr Opin Ophthalmol 10:474\u2013482. https:\/\/doi.org\/10.1097\/00055735-199912000-00017","journal-title":"Curr Opin Ophthalmol"},{"key":"3687_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-25264-4","volume":"8","author":"AK van Koeverden","year":"2018","unstructured":"van Koeverden AK, He Z, Nguyen CTO, Vingrys AJ, Bui BV (2018) Systemic hypertension is not protective against chronic intraocular pressure elevation in a rodent model. Sci Rep 8:7107. https:\/\/doi.org\/10.1038\/s41598-018-25264-4","journal-title":"Sci Rep"},{"key":"3687_CR94","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8377362","volume":"2021","author":"L Pan","year":"2021","unstructured":"Pan L, Cho K-S, Yi I, To C-H, Chen DF, Do C-W (2021) Baicalein, baicalin, and wogonin: protective effects against ischemia-induced neurodegeneration in the brain and retina. Oxid Med Cell Longev 2021:8377362. https:\/\/doi.org\/10.1155\/2021\/8377362","journal-title":"Oxid Med Cell Longev"},{"key":"3687_CR95","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s00417-020-04983-3","volume":"259","author":"L Chen","year":"2021","unstructured":"Chen L, Yuan M, Sun L, Chen Y (2021) Choroidal thickening in retinal vein occlusion patients with serous retinal detachment. Graefes Arch Clin Exp Ophthalmol 259:883\u2013889. https:\/\/doi.org\/10.1007\/s00417-020-04983-3","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3687_CR96","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S1350-9462(00)00020-3","volume":"20","author":"IO Haefliger","year":"2001","unstructured":"Haefliger IO, Flammer J, B\u00e9ny J-L, L\u00fcscher TF (2001) Endothelium-dependent vasoactive modulation in the ophthalmic circulation. Prog Retin Eye Res 20:209\u2013225. https:\/\/doi.org\/10.1016\/S1350-9462(00)00020-3","journal-title":"Prog Retin Eye Res"},{"key":"3687_CR97","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0014-4835(91)90256-E","volume":"52","author":"ME Langham","year":"1991","unstructured":"Langham ME, Grebe R, Hopkins S, Marcus S, Sebag M (1991) Choroidal blood flow in diabetic retinopathy. Exp Eye Res 52:167\u2013173. https:\/\/doi.org\/10.1016\/0014-4835(91)90256-E","journal-title":"Exp Eye Res"},{"key":"3687_CR98","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-74058-0","volume":"10","author":"SU Choi","year":"2020","unstructured":"Choi SU, Oh JY, Kim JT (2020) Correlations between choroidal thickness and renal function in patients with retinal vein occlusion. Sci Rep 10:16865. https:\/\/doi.org\/10.1038\/s41598-020-74058-0","journal-title":"Sci Rep"},{"key":"3687_CR99","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.survophthal.2012.12.001","volume":"58","author":"S Mrejen","year":"2013","unstructured":"Mrejen S, Spaide RF (2013) Optical coherence tomography: imaging of the choroid and beyond. Surv Ophthalmol 58:387\u2013429. https:\/\/doi.org\/10.1016\/j.survophthal.2012.12.001","journal-title":"Surv Ophthalmol"},{"key":"3687_CR100","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1159\/000342158","volume":"229","author":"MK Ikram","year":"2013","unstructured":"Ikram MK, Ong YT, Cheung CY, Wong TY (2013) Retinal vascular caliber measurements: clinical significance, current knowledge and future perspectives. Ophthalmologica 229:125\u2013136. https:\/\/doi.org\/10.1159\/000342158","journal-title":"Ophthalmologica"},{"key":"3687_CR101","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1161\/HYPERTENSIONAHA.111.189142","volume":"60","author":"CY Cheung","year":"2012","unstructured":"Cheung CY, Ikram MK, Sabanayagam C, Wong TY (2012) Retinal microvasculature as a model to study the manifestations of hypertension. Hypertension 60:1094\u20131103. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.111.189142","journal-title":"Hypertension"},{"key":"3687_CR102","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/dme.12089","volume":"30","author":"LZ Heng","year":"2013","unstructured":"Heng LZ, Comyn O, Peto T, Tadros C, Ng E, Sivaprasad S, Hykin PG (2013) Diabetic retinopathy: pathogenesis, clinical grading, management and future developments. Diabet Med 30:640\u2013650. https:\/\/doi.org\/10.1111\/dme.12089","journal-title":"Diabet Med"},{"key":"3687_CR103","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1159\/000455278","volume":"58","author":"JB Jonas","year":"2017","unstructured":"Jonas JB, Mon\u00e9s J, Glacet-Bernard A, Coscas G (2017) Retinal vein occlusions. Dev Ophthalmol 58:139\u2013167. https:\/\/doi.org\/10.1159\/000455278","journal-title":"Dev Ophthalmol"},{"key":"3687_CR104","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/HJH.0b013e32836586f4","volume":"32","author":"J Ding","year":"2014","unstructured":"Ding J, Wai KL, McGeechan K, Ikram MK, Kawasaki R, Xie J, Klein R, Klein BBK, Cotch MF, Wang JJ, Mitchell P, Shaw JE, Takamasa K, Sharrett AR, Wong TY (2014) Retinal vascular caliber and the development of hypertension. J Hypertens 32:207\u2013215. https:\/\/doi.org\/10.1097\/HJH.0b013e32836586f4","journal-title":"J Hypertens"},{"key":"3687_CR105","first-page":"1113","volume":"25","author":"A Bruun","year":"1984","unstructured":"Bruun A, Ehinger B, Sundler F, Tornqvist K, Uddman R (1984) Neuropeptide Y immunoreactive neurons in the guinea-pig uvea and retina. Invest Ophthalmol Vis Sci 25:1113\u20131123","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3687_CR106","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1093\/ajh\/hpaa074","volume":"33","author":"JM Wyss","year":"2020","unstructured":"Wyss JM (2020) Sympathetic activation in hypertension: importance of the central nervous system. Am J Hypertens 33:914\u2013926. https:\/\/doi.org\/10.1093\/ajh\/hpaa074","journal-title":"Am J Hypertens"},{"key":"3687_CR107","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1038\/jcbfm.2013.137","volume":"33","author":"A Boltz","year":"2013","unstructured":"Boltz A, Schmidl D, Werkmeister RM, Lasta M, Kaya S, Palkovits S, Told R, Napora KJ, Popa-Cherecheanu A, Garh\u00f6fer G, Schmetterer L (2013) Regulation of optic nerve head blood flow during combined changes in intraocular pressure and arterial blood pressure. J Cereb Blood Flow Metab 33:1850\u20131856. https:\/\/doi.org\/10.1038\/jcbfm.2013.137","journal-title":"J Cereb Blood Flow Metab"},{"key":"3687_CR108","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.preteyeres.2008.02.002","volume":"27","author":"CJ Pournaras","year":"2008","unstructured":"Pournaras CJ, Rungger-Br\u00e4ndle E, Riva CE, Hardarson SH, Stefansson E (2008) Regulation of retinal blood flow in health and disease. Prog Retin Eye Res 27:284\u2013330. https:\/\/doi.org\/10.1016\/j.preteyeres.2008.02.002","journal-title":"Prog Retin Eye Res"},{"issue":"11","key":"3687_CR109","doi-asserted-by":"publisher","DOI":"10.3390\/nu14112200","volume":"14","author":"R Del Pinto","year":"2022","unstructured":"Del Pinto R, Mul\u00e8 G, Vadal\u00e0 M, Carollo C, Cottone S, Agabiti Rosei C, De Ciuceis C, Rizzoni D, Ferri C, Muiesan ML (2022) Arterial hypertension and the hidden disease of the eye: diagnostic tools and therapeutic strategies. Nutrients 14(11):2200. https:\/\/doi.org\/10.3390\/nu14112200","journal-title":"Nutrients"},{"key":"3687_CR110","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ajo.2016.07.023","volume":"170","author":"RF Spaide","year":"2016","unstructured":"Spaide RF (2016) Choriocapillaris flow features follow a power law distribution: implications for characterization and mechanisms of disease progression. Am J Ophthalmol 170:58\u201367. https:\/\/doi.org\/10.1016\/j.ajo.2016.07.023","journal-title":"Am J Ophthalmol"},{"key":"3687_CR111","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3389\/fendo.2013.00158","volume":"4","author":"JW Wright","year":"2013","unstructured":"Wright JW, Kawas LH, Harding JW (2013) A Role for the brain RAS in Alzheimer\u2019s and Parkinson\u2019s diseases. Front Endocrinol 4:158. https:\/\/doi.org\/10.3389\/fendo.2013.00158","journal-title":"Front Endocrinol"},{"key":"3687_CR112","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1016\/j.ajpath.2011.02.006","volume":"178","author":"M Pons","year":"2011","unstructured":"Pons M, Cousins SW, Alcazar O, Striker GE, Marin-Casta\u00f1o ME (2011) Angiotensin II\u2013induced MMP-2 activity and MMP-14 and basigin protein expression are mediated via the angiotensin II receptor type 1\u2013mitogen-activated protein kinase 1 pathway in retinal pigment epithelium. Am J Pathol 178:2665\u20132681. https:\/\/doi.org\/10.1016\/j.ajpath.2011.02.006","journal-title":"Am J Pathol"},{"key":"3687_CR113","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0304-3940(97)00520-X","volume":"231","author":"E Guenther","year":"1997","unstructured":"Guenther E, Hewig B, Zrenner E, Kohler K (1997) Angiotensin II-induced inhibition and facilitation of calcium current subtypes in rat retinal ganglion cells. Neurosci Lett 231:71\u201374. https:\/\/doi.org\/10.1016\/S0304-3940(97)00520-X","journal-title":"Neurosci Lett"},{"key":"3687_CR114","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/0006-8993(96)00077-7","volume":"718","author":"E Guenther","year":"1996","unstructured":"Guenther E, Schmid S, Hewig B, Kohler K (1996) Two-fold effect of Angiotensin II on voltage-dependent calcium currents in rat retinal ganglion cells. Brain Res 718:112\u2013116. https:\/\/doi.org\/10.1016\/0006-8993(96)00077-7","journal-title":"Brain Res"},{"key":"3687_CR115","doi-asserted-by":"publisher","first-page":"122","DOI":"10.2174\/1874364101711010122","volume":"11","author":"M Holappa","year":"2017","unstructured":"Holappa M, Vapaatalo H, Vaajanen A (2017) Many faces of renin-angiotensin system - focus on eye. TOOPHTJ 11:122\u2013142. https:\/\/doi.org\/10.2174\/1874364101711010122","journal-title":"TOOPHTJ"},{"key":"3687_CR116","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1080\/07853890802043924","volume":"40","author":"A Vaajanen","year":"2008","unstructured":"Vaajanen A, Luhtala S, Oksala O, Vapaatalo H (2008) Does the renin-angiotensin system also regulate intra-ocular pressure? Ann Med 40:418\u2013427. https:\/\/doi.org\/10.1080\/07853890802043924","journal-title":"Ann Med"},{"key":"3687_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2019.107788","volume":"188","author":"MJ Allingham","year":"2019","unstructured":"Allingham MJ, Mettu PS, Cousins SW (2019) Aldosterone as a mediator of severity in retinal vascular disease: evidence and potential mechanisms. Exp Eye Res 188:107788. https:\/\/doi.org\/10.1016\/j.exer.2019.107788","journal-title":"Exp Eye Res"},{"key":"3687_CR118","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/ajh\/hpy158","volume":"32","author":"LA Biwer","year":"2019","unstructured":"Biwer LA, Wallingford MC, Jaffe IZ (2019) Vascular mineralocorticoid receptor: evolutionary mediator of wound healing turned harmful by our modern lifestyle. Am J Hypertens 32:123\u2013134. https:\/\/doi.org\/10.1093\/ajh\/hpy158","journal-title":"Am J Hypertens"},{"key":"3687_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111426","volume":"124","author":"Y Ruan","year":"2024","unstructured":"Ruan Y, Yu Y, Wu M, Jiang Y, Qiu Y, Ruan S (2024) The renin-angiotensin-aldosterone system: an old tree sprouts new shoots. Cell Signal 124:111426. https:\/\/doi.org\/10.1016\/j.cellsig.2024.111426","journal-title":"Cell Signal"},{"key":"3687_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111343","volume":"122","author":"F Buonfiglio","year":"2024","unstructured":"Buonfiglio F, Pfeiffer N, Gericke A (2024) Glaucoma and the ocular renin-angiotensin-aldosterone system: update on molecular signalling and treatment perspectives. Cell Signal 122:111343. https:\/\/doi.org\/10.1016\/j.cellsig.2024.111343","journal-title":"Cell Signal"},{"key":"3687_CR121","doi-asserted-by":"publisher","DOI":"10.2174\/1573399817999210111205933","volume":"18","author":"MD Dennis","year":"2022","unstructured":"Dennis MD, Dierschke SK (2022) Retinal protein O-GlcNAcylation and the ocular renin-angiotensin system: signaling cross-roads in diabetic retinopathy. CDR 18:e011121190177. https:\/\/doi.org\/10.2174\/1573399817999210111205933","journal-title":"CDR"},{"key":"3687_CR122","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/07853890.2020.1758341","volume":"52","author":"M Holappa","year":"2020","unstructured":"Holappa M, Vapaatalo H, Vaajanen A (2020) Local ocular renin\u2013angiotensin\u2013aldosterone system: any connection with intraocular pressure? A comprehensive review. Ann Med 52:191\u2013206. https:\/\/doi.org\/10.1080\/07853890.2020.1758341","journal-title":"Ann Med"},{"issue":"3","key":"3687_CR123","doi-asserted-by":"publisher","DOI":"10.3390\/ph16030345","volume":"16","author":"FK Alswailmi","year":"2023","unstructured":"Alswailmi FK (2023) A cross talk between the Endocannabinoid system and different systems involved in the pathogenesis of hypertensive retinopathy. Pharmaceuticals 16(3):345. https:\/\/doi.org\/10.3390\/ph16030345","journal-title":"Pharmaceuticals"},{"key":"3687_CR124","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqac201","volume":"164","author":"T Higashide","year":"2022","unstructured":"Higashide T, Hirooka K, Kometani M, Sugiyama K (2022) Aldosterone as a possible contributor to eye diseases. Endocrinology 164:bqac201. https:\/\/doi.org\/10.1210\/endocr\/bqac201","journal-title":"Endocrinology"},{"key":"3687_CR125","doi-asserted-by":"publisher","first-page":"F396","DOI":"10.1152\/ajprenal.00576.2009","volume":"299","author":"VM Milenkovic","year":"2010","unstructured":"Milenkovic VM, Brockmann M, Meyer C, Desch M, Schweda F, Kurtz A, Todorov V, Strauss O (2010) Regulation of the renin expression in the retinal pigment epithelium by systemic stimuli. Am J Physiol Renal Physiol 299:F396\u2013F403. https:\/\/doi.org\/10.1152\/ajprenal.00576.2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"3687_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2019.107828","volume":"189","author":"JR Martins","year":"2019","unstructured":"Martins JR, Reichhart N, Kociok N, Stindl J, Foeckler R, Lachmann P, Todorov V, Castrop H, Strau\u00df O (2019) Systemic \u00df adrenergic stimulation\/ sympathetic nerve system stimulation influences intraocular RAS through cAMP in the RPE. Exp Eye Res 189:107828. https:\/\/doi.org\/10.1016\/j.exer.2019.107828","journal-title":"Exp Eye Res"},{"key":"3687_CR127","doi-asserted-by":"publisher","first-page":"9690","DOI":"10.1074\/jbc.M114.626713","volume":"290","author":"A Kanda","year":"2015","unstructured":"Kanda A, Noda K, Ishida S (2015) ATP6AP2\/(Pro)renin receptor contributes to glucose metabolism via stabilizing the pyruvate dehydrogenase E1 \u03b2 subunit. J Biol Chem 290:9690\u20139700. https:\/\/doi.org\/10.1074\/jbc.M114.626713","journal-title":"J Biol Chem"},{"key":"3687_CR128","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25147717","volume":"25","author":"H Ohguro","year":"2024","unstructured":"Ohguro H, Watanabe M, Hikage F, Sato T, Nishikiori N, Umetsu A, Higashide M, Ogawa T, Furuhashi M (2024) Fatty acid-binding protein 4-mediated regulation is pivotally involved in retinal pathophysiology: a review. IJMS 25:7717. https:\/\/doi.org\/10.3390\/ijms25147717","journal-title":"IJMS"},{"key":"3687_CR129","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0049624","volume":"7","author":"R Barro-Soria","year":"2012","unstructured":"Barro-Soria R, Stindl J, M\u00fcller C, Foeckler R, Todorov V, Castrop H, Strau\u00df O (2012) Angiotensin-2-mediated Ca2+ signaling in the retinal pigment epithelium: role of angiotensin-receptor- associated-protein and TRPV2 channel. PLoS One 7:e49624. https:\/\/doi.org\/10.1371\/journal.pone.0049624","journal-title":"PLoS One"},{"key":"3687_CR130","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21197170","volume":"21","author":"Y Murakami","year":"2020","unstructured":"Murakami Y, Nakabeppu Y, Sonoda K-H (2020) Oxidative stress and microglial response in retinitis pigmentosa. IJMS 21:7170. https:\/\/doi.org\/10.3390\/ijms21197170","journal-title":"IJMS"},{"key":"3687_CR131","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1167\/iovs.17-23073","volume":"59","author":"MJ Allingham","year":"2018","unstructured":"Allingham MJ, Tserentsoodol N, Saloupis P, Mettu PS, Cousins SW (2018) Aldosterone exposure causes increased retinal edema and severe retinopathy following laser-induced retinal vein occlusion in mice. Invest Ophthalmol Vis Sci 59:3355. https:\/\/doi.org\/10.1167\/iovs.17-23073","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3687_CR132","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1016\/j.ophtha.2006.05.037","volume":"113","author":"N Miyamoto","year":"2006","unstructured":"Miyamoto N, Iossifov D, Metge F, Behar-Cohen F (2006) Early effects of intravitreal triamcinolone on macular edema. Ophthalmology 113:2048\u20132053. https:\/\/doi.org\/10.1016\/j.ophtha.2006.05.037","journal-title":"Ophthalmology"},{"key":"3687_CR133","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22179618","volume":"22","author":"J Canonica","year":"2021","unstructured":"Canonica J, Zhao M, Favez T, Geliz\u00e9 E, Jonet L, Kowalczuk L, Guegan J, Le Menuet D, Viengchareun S, Lomb\u00e8s M, Pussard E, Arsenijevic Y, Behar-Cohen F (2021) Pathogenic effects of mineralocorticoid pathway activation in retinal pigment epithelium. IJMS 22:9618. https:\/\/doi.org\/10.3390\/ijms22179618","journal-title":"IJMS"},{"key":"3687_CR134","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032334","volume":"24","author":"JR Jerome","year":"2023","unstructured":"Jerome JR, Deliyanti D, Suphapimol V, Kolkhof P, Wilkinson-Berka JL (2023) Finerenone, a non-steroidal mineralocorticoid receptor antagonist, reduces vascular injury and increases regulatory T-cells: studies in rodents with diabetic and neovascular retinopathy. IJMS 24:2334. https:\/\/doi.org\/10.3390\/ijms24032334","journal-title":"IJMS"},{"key":"3687_CR135","doi-asserted-by":"publisher","DOI":"10.1621\/nrs.05012","volume":"5","author":"S Viengchareun","year":"2007","unstructured":"Viengchareun S, Le Menuet D, Martinerie L, Munier M, Tallec LP-L, Lomb\u00e8s M (2007) The Mineralocorticoid Receptor: Insights into its Molecular and (Patho)Physiological Biology. Nucl Recept Signal 5:e012. https:\/\/doi.org\/10.1621\/nrs.05012","journal-title":"Nucl Recept Signal"},{"key":"3687_CR136","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1096\/fj.09-154344","volume":"24","author":"M Zhao","year":"2010","unstructured":"Zhao M, Valamanesh F, Celerier I, Savoldelli M, Jonet L, Jeanny J, Jaisser F, Farman N, Behar-Cohen F (2010) The neuroretina is a novel mineralocorticoid target: aldosterone up-regulates ion and water channels in M\u00fcller glial cells. FASEB J 24:3405\u20133415. https:\/\/doi.org\/10.1096\/fj.09-154344","journal-title":"FASEB J"},{"key":"3687_CR137","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/j.bbagen.2013.10.037","volume":"1840","author":"KL Schey","year":"2014","unstructured":"Schey KL, Wang Z, Wenke JL, Qi Y (2014) Aquaporins in the eye Expression function and roles in ocular disease. Biochimica et Biophys Acta (BBA) Gen Subj 1840:1513\u20131523. https:\/\/doi.org\/10.1016\/j.bbagen.2013.10.037","journal-title":"Biochimica et Biophys Acta (BBA) Gen Subj"},{"key":"3687_CR138","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.preteyeres.2006.05.003","volume":"25","author":"A Bringmann","year":"2006","unstructured":"Bringmann A, Pannicke T, Grosche J, Francke M, Wiedemann P, Skatchkov S, Osborne N, Reichenbach A (2006) M\u00fcller cells in the healthy and diseased retina. Prog Retin Eye Res 25:397\u2013424. https:\/\/doi.org\/10.1016\/j.preteyeres.2006.05.003","journal-title":"Prog Retin Eye Res"},{"key":"3687_CR139","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1167\/iovs.03-0001","volume":"44","author":"WD Stamer","year":"2003","unstructured":"Stamer WD, Bok D, Hu J, Jaffe GJ, McKay BS (2003) Aquaporin-1 channels in human retinal pigment epithelium: role in transepithelial water movement. Invest Ophthalmol Vis Sci 44:2803. https:\/\/doi.org\/10.1167\/iovs.03-0001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3687_CR140","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1167\/iovs.62.2.24","volume":"62","author":"S Ueki","year":"2021","unstructured":"Ueki S, Suzuki Y, Igarashi H (2021) Retinal aquaporin-4 and regulation of water inflow into the vitreous body. Invest Ophthalmol Vis Sci 62:24. https:\/\/doi.org\/10.1167\/iovs.62.2.24","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3687_CR141","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1113\/jphysiol.1997.sp022045","volume":"500","author":"S Kusaka","year":"1997","unstructured":"Kusaka S, Puro DG (1997) Intracellular ATP activates inwardly rectifying K+ channels in human and monkey retinal M\u00fcller (glial) cells. J Physiol 500:593\u2013604. https:\/\/doi.org\/10.1113\/jphysiol.1997.sp022045","journal-title":"J Physiol"},{"key":"3687_CR142","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/j.1600-0420.2005.00565.x","volume":"83","author":"A Bringmann","year":"2005","unstructured":"Bringmann A, Uckermann O, Pannicke T, Iandiev I, Reichenbach A, Wiedemann P (2005) Neuronal versus glial cell swelling in the ischaemic retina. Acta Ophthalmol Scand 83:528\u2013538. https:\/\/doi.org\/10.1111\/j.1600-0420.2005.00565.x","journal-title":"Acta Ophthalmol Scand"},{"key":"3687_CR143","doi-asserted-by":"publisher","first-page":"4477","DOI":"10.1167\/iovs.04-0940","volume":"45","author":"T Da","year":"2004","unstructured":"Da T, Verkman AS (2004) Aquaporin-4 gene disruption in mice protects against impaired retinal function and cell death after ischemia. Invest Ophthalmol Vis Sci 45:4477. https:\/\/doi.org\/10.1167\/iovs.04-0940","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3687_CR144","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2019.107766","volume":"187","author":"JL Wilkinson-Berka","year":"2019","unstructured":"Wilkinson-Berka JL, Suphapimol V, Jerome JR, Deliyanti D, Allingham MJ (2019) Angiotensin II and aldosterone in retinal vasculopathy and inflammation. Exp Eye Res 187:107766. https:\/\/doi.org\/10.1016\/j.exer.2019.107766","journal-title":"Exp Eye Res"},{"key":"3687_CR145","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1161\/ATVBAHA.114.303792","volume":"34","author":"D Deliyanti","year":"2014","unstructured":"Deliyanti D, Armani R, Casely D, Figgett WA, Agrotis A, Wilkinson-Berka JL (2014) Retinal vasculopathy is reduced by dietary salt restriction. ATVB 34:2033\u20132041. https:\/\/doi.org\/10.1161\/ATVBAHA.114.303792","journal-title":"ATVB"},{"key":"3687_CR146","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.65.12.39","volume":"65","author":"B Leclercq","year":"2024","unstructured":"Leclercq B, Mejlachowicz D, Zhu L, Jonet L, Mehanna C, Berdugo M, Irinopoulou T, Jaisser F, Zhao M, Behar-Cohen F (2024) Differential effect of aldosterone or mineralocorticoid receptor overexpression on retinal inflammation. Invest Ophthalmol Vis Sci 65:39. https:\/\/doi.org\/10.1167\/iovs.65.12.39","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3687_CR147","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1172\/JCI61427","volume":"122","author":"M Zhao","year":"2012","unstructured":"Zhao M, C\u00e9l\u00e9rier I, Bousquet E, Jeanny J-C, Jonet L, Savoldelli M, Offret O, Curan A, Farman N, Jaisser F, Behar-Cohen F (2012) Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy. J Clin Invest 122:2672\u20132679. https:\/\/doi.org\/10.1172\/JCI61427","journal-title":"J Clin Invest"},{"key":"3687_CR148","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2019.107747","volume":"187","author":"J Canonica","year":"2019","unstructured":"Canonica J, Mehanna C, Bonnard B, Jonet L, Gelize E, Jais J-P, Jaisser F, Zhao M, Behar-Cohen F (2019) Effect of acute and chronic aldosterone exposure on the retinal pigment epithelium-choroid complex in rodents. Exp Eye Res 187:107747. https:\/\/doi.org\/10.1016\/j.exer.2019.107747","journal-title":"Exp Eye Res"},{"key":"3687_CR149","doi-asserted-by":"publisher","first-page":"8241","DOI":"10.2147\/JIR.S488553","volume":"17","author":"X Fan","year":"2024","unstructured":"Fan X, Zhang W, Zheng R, Zhang Y, Lai X, Han J, Fang Z, Han B, Huang W, Ye B, Dai S (2024) GSDMD mediates Ang II-induced hypertensive nephropathy by regulating the GATA2\/AQP4 signaling pathway. J Inflamm Res 17:8241\u20138259. https:\/\/doi.org\/10.2147\/JIR.S488553","journal-title":"J Inflamm Res"},{"key":"3687_CR150","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.neuroscience.2016.01.003","volume":"317","author":"H Sun","year":"2016","unstructured":"Sun H, Liang R, Yang B, Zhou Y, Liu M, Fang F, Ding J, Fan Y, Hu G (2016) Aquaporin-4 mediates communication between astrocyte and microglia: implications of neuroinflammation in experimental Parkinson\u2019s disease. Neuroscience 317:65\u201375. https:\/\/doi.org\/10.1016\/j.neuroscience.2016.01.003","journal-title":"Neuroscience"},{"key":"3687_CR151","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.3390\/ijms22041845","volume":"22","author":"IV da Silva","year":"2021","unstructured":"da Silva IV, Soveral G (2021) Aquaporins in immune cells and inflammation: new targets for drug development. IJMS 22:1845. https:\/\/doi.org\/10.3390\/ijms22041845","journal-title":"IJMS"},{"key":"3687_CR152","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1111\/bph.15770","volume":"179","author":"F Behar-Cohen","year":"2022","unstructured":"Behar-Cohen F, Zhao M (2022) Mineralocorticoid pathway in retinal health and diseases. Br J Pharmacol 179:3190\u20133204. https:\/\/doi.org\/10.1111\/bph.15770","journal-title":"Br J Pharmacol"},{"key":"3687_CR153","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3389\/fphys.2017.00371","volume":"8","author":"MV Clausen","year":"2017","unstructured":"Clausen MV, Hilbers F, Poulsen H (2017) The structure and function of the Na,K-ATPase isoforms in health and disease. Front Physiol 8:371. https:\/\/doi.org\/10.3389\/fphys.2017.00371","journal-title":"Front Physiol"},{"key":"3687_CR154","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1080\/10799893.2017.1369120","volume":"37","author":"R Haque","year":"2017","unstructured":"Haque R, Iuvone PM, He L, Hur EH, Chung Choi KS, Park D, Farrell AN, Ngo A, Gokhale S, Aseem M, Kumar B (2017) Prorenin receptor (PRR)-mediated NADPH oxidase (Nox) signaling regulates VEGF synthesis under hyperglycemic condition in ARPE-19 cells. J Recept Signal Transduct Res 37:560\u2013568. https:\/\/doi.org\/10.1080\/10799893.2017.1369120","journal-title":"J Recept Signal Transduct Res"},{"key":"3687_CR155","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1111\/bph.13403","volume":"174","author":"A Daiber","year":"2017","unstructured":"Daiber A, Di Lisa F, Oelze M, Kr\u00f6ller-Sch\u00f6n S, Steven S, Schulz E, M\u00fcnzel T (2017) Crosstalk of mitochondria with NADPH oxidase via reactive oxygen and nitrogen species signalling and its role for vascular function. Br J Pharmacol 174:1670\u20131689. https:\/\/doi.org\/10.1111\/bph.13403","journal-title":"Br J Pharmacol"},{"key":"3687_CR156","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/bs.vh.2018.09.005","volume":"109","author":"A Cannavo","year":"2019","unstructured":"Cannavo A, Elia A, Liccardo D, Rengo G, Koch WJ (2019) Aldosterone and myocardial pathology. Vitam Horm 109:387\u2013406. https:\/\/doi.org\/10.1016\/bs.vh.2018.09.005","journal-title":"Vitam Horm"},{"key":"3687_CR157","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1161\/01.CIR.0000127112.36796.9B","volume":"109","author":"F Michel","year":"2004","unstructured":"Michel F, Ambroisine M-L, Duriez M, Delcayre C, Levy BI, Silvestre J-S (2004) Aldosterone enhances ischemia-induced neovascularization through angiotensin II\u2013dependent pathway. Circulation 109:1933\u20131937. https:\/\/doi.org\/10.1161\/01.CIR.0000127112.36796.9B","journal-title":"Circulation"},{"key":"3687_CR158","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1161\/01.CIR.94.10.2566","volume":"94","author":"N Klauber","year":"1996","unstructured":"Klauber N, Browne F, Anand-Apte B, D\u2019Amato RJ (1996) New activity of spironolactone. Circulation 94:2566\u20132571. https:\/\/doi.org\/10.1161\/01.CIR.94.10.2566","journal-title":"Circulation"},{"key":"3687_CR159","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41467-018-08125-6","volume":"10","author":"M Zhao","year":"2019","unstructured":"Zhao M, Mantel I, Gelize E, Li X, Xie X, Arboleda A, Seminel M, Levy-Boukris R, Dernigoghossian M, Prunotto A, Andrieu-Soler C, Rivolta C, Canonica J, Naud M-C, Lechner S, Farman N, Bravo-Osuna I, Herrero-Vanrell R, Jaisser F, Behar-Cohen F (2019) Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration. Nat Commun 10:369. https:\/\/doi.org\/10.1038\/s41467-018-08125-6","journal-title":"Nat Commun"},{"key":"3687_CR160","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0006-8993(95)00578-E","volume":"690","author":"JA De Juan","year":"1995","unstructured":"De Juan JA, Moya FJ, Fernandez-Cruz A, Fernandez-Durango R (1995) Identification of endothelin receptor subtypes in rat retina using subtype-selective ligands. Brain Res 690:25\u201333. https:\/\/doi.org\/10.1016\/0006-8993(95)00578-E","journal-title":"Brain Res"},{"key":"3687_CR161","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1001\/archopht.1994.01090210119024","volume":"112","author":"MW MacCumber","year":"1994","unstructured":"MacCumber MW (1994) Endothelin receptor-binding subtypes in the human retina and choroid. Arch Ophthalmol 112:1231. https:\/\/doi.org\/10.1001\/archopht.1994.01090210119024","journal-title":"Arch Ophthalmol"},{"key":"3687_CR162","doi-asserted-by":"publisher","first-page":"126","DOI":"10.14744\/bej.2022.44265","volume":"7","author":"E Bozkurt","year":"2022","unstructured":"Bozkurt E (2022) Evaluation of systemic endothelial dysfunction in retinal vein occlusions. Beyoglu Eye J 7:126\u2013133. https:\/\/doi.org\/10.14744\/bej.2022.44265","journal-title":"Beyoglu Eye J"},{"key":"3687_CR163","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13167-015-0043-1","volume":"6","author":"J Flammer","year":"2015","unstructured":"Flammer J, Konieczka K (2015) Retinal venous pressure: the role of endothelin. EPMA J 6:21. https:\/\/doi.org\/10.1186\/s13167-015-0043-1","journal-title":"EPMA J"},{"key":"3687_CR164","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1159\/000527446","volume":"66","author":"M Pan","year":"2023","unstructured":"Pan M, Zhou P, Guo J, An G, Liu Z, Du L, Jin X (2023) Elevated neutrophil counts, triglycerides, monocyte\/high-density lipoprotein ratios, and lower high-density lipoprotein in patients with retinal vein occlusion. Ophthal Res 66:265\u2013271. https:\/\/doi.org\/10.1159\/000527446","journal-title":"Ophthal Res"},{"key":"3687_CR165","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.exer.2018.07.016","volume":"176","author":"T Kida","year":"2018","unstructured":"Kida T, Flammer J, Oku H, Konieczka K, Morishita S, Horie T, Ikeda T (2018) Vasoactivity of retinal veins: a potential involvement of endothelin-1 (ET-1) in the pathogenesis of retinal vein occlusion (RVO). Exp Eye Res 176:207\u2013209. https:\/\/doi.org\/10.1016\/j.exer.2018.07.016","journal-title":"Exp Eye Res"},{"key":"3687_CR166","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s12886-020-01534-6","volume":"20","author":"M Matsuzawa","year":"2020","unstructured":"Matsuzawa M, Sakanishi Y, Ebihara N (2020) Seasonal variation in the occurrence of retinal vein occlusion: a 4-year cross-sectional study. BMC Ophthalmol 20:265. https:\/\/doi.org\/10.1186\/s12886-020-01534-6","journal-title":"BMC Ophthalmol"},{"key":"3687_CR167","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.preteyeres.2013.02.001","volume":"34","author":"I Klaassen","year":"2013","unstructured":"Klaassen I, Van Noorden CJF, Schlingemann RO (2013) Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions. Prog Retin Eye Res 34:19\u201348. https:\/\/doi.org\/10.1016\/j.preteyeres.2013.02.001","journal-title":"Prog Retin Eye Res"},{"key":"3687_CR168","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3928\/23258160-20200326-01","volume":"51","author":"KB Freund","year":"2020","unstructured":"Freund KB, Fine HF (2020) Pachychoroid disease. Ophthalmic Surg Lasers Imaging Retina 51:206\u2013209. https:\/\/doi.org\/10.3928\/23258160-20200326-01","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"3687_CR169","doi-asserted-by":"publisher","first-page":"e806","DOI":"10.1111\/aos.14683","volume":"99","author":"S Borooah","year":"2021","unstructured":"Borooah S, Sim PY, Phatak S, Moraes G, Wu CY, Cheung CMG, Pal B, Bujarborua D (2021) Pachychoroid spectrum disease. Acta Ophthalmol 99:e806\u2013e822. https:\/\/doi.org\/10.1111\/aos.14683","journal-title":"Acta Ophthalmol"},{"key":"3687_CR170","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-99115-0","volume":"11","author":"LF Keidel","year":"2021","unstructured":"Keidel LF, Zwingelberg S, Schworm B, Luft N, Herold T, Priglinger SG, Siedlecki J (2021) Pachychoroid disease and its association with retinal vein occlusion: a case\u2013control study. Sci Rep 11:19854. https:\/\/doi.org\/10.1038\/s41598-021-99115-0","journal-title":"Sci Rep"},{"key":"3687_CR171","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1177\/000331970005100606","volume":"51","author":"A Gotts\u00e4ter","year":"2000","unstructured":"Gotts\u00e4ter A, Anwaar I, Eriksson KF, Mattiasson I, Lindg\u00e4rde F (2000) Homocysteine is related to neopterin and endothelin-1 in plasma of subjects with disturbed glucose metabolism and reference subjects. Angiology 51:489\u2013497. https:\/\/doi.org\/10.1177\/000331970005100606","journal-title":"Angiology"},{"key":"3687_CR172","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2170\/jjphysiol.45.347","volume":"45","author":"S Abe","year":"1995","unstructured":"Abe S, Karita K, Izumi H, Tamai M (1995) Increased and decreased choroidal blood flow elicited by cervical sympathetic nerve stimulation in the cat. Jpn J Physiol 45:347\u2013353. https:\/\/doi.org\/10.2170\/jjphysiol.45.347","journal-title":"Jpn J Physiol"},{"key":"3687_CR173","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/s0161-6420(89)32936-8","volume":"96","author":"E Friedman","year":"1989","unstructured":"Friedman E, Ivry M, Ebert E, Glynn R, Gragoudas E, Seddon J (1989) Increased scleral rigidity and age-related macular degeneration. Ophthalmology 96:104\u2013108. https:\/\/doi.org\/10.1016\/s0161-6420(89)32936-8","journal-title":"Ophthalmology"},{"key":"3687_CR174","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/724780","volume":"2014","author":"P Kolar","year":"2014","unstructured":"Kolar P (2014) Risk factors for central and branch retinal vein occlusion: a meta-analysis of published clinical data. J Ophthalmol 2014:724780. https:\/\/doi.org\/10.1155\/2014\/724780","journal-title":"J Ophthalmol"},{"key":"3687_CR175","doi-asserted-by":"publisher","first-page":"e534","DOI":"10.7417\/CT.2020.2269","volume":"171","author":"F Pacella","year":"2020","unstructured":"Pacella F, Bongiovanni G, Malvasi M, Trovato Battagliola E, Pistone A, Scalinci SZ, Basili S, La Torre G, Pacella E (2020) Impact of cardiovascular risk factors on incidence and severity of Retinal Vein Occlusion. Clin Ter 171:e534\u2013e538. https:\/\/doi.org\/10.7417\/CT.2020.2269","journal-title":"Clin Ter"},{"key":"3687_CR176","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11164756","volume":"11","author":"P Loiudice","year":"2022","unstructured":"Loiudice P, Covello G, Figus M, Posarelli C, Sartini MS, Casini G (2022) Choroidal vascularity index in central and branch retinal vein occlusion. J Clin Med 11:4756. https:\/\/doi.org\/10.3390\/jcm11164756","journal-title":"J Clin Med"},{"key":"3687_CR177","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.preteyeres.2012.04.004","volume":"31","author":"J Kur","year":"2012","unstructured":"Kur J, Newman EA, Chan-Ling T (2012) Cellular and physiological mechanisms underlying blood flow regulation in the retina and choroid in health and disease. Prog Retin Eye Res 31:377\u2013406. https:\/\/doi.org\/10.1016\/j.preteyeres.2012.04.004","journal-title":"Prog Retin Eye Res"},{"key":"3687_CR178","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0074-7742(09)00403-6","volume":"84","author":"JC de la Torre","year":"2009","unstructured":"de la Torre JC (2009) Chapter 3 cerebrovascular and cardiovascular pathology in Alzheimer\u2019s disease. Int Rev Neurobiol 84:35\u201348. https:\/\/doi.org\/10.1016\/S0074-7742(09)00403-6","journal-title":"Int Rev Neurobiol"},{"key":"3687_CR179","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.bbrc.2018.12.049","volume":"508","author":"J-P Xia","year":"2019","unstructured":"Xia J-P, Wang S, Zhang J-S (2019) The anti-inflammatory and anti-oxidative effects of conbercept in treatment of macular edema secondary to retinal vein occlusion. Biochem Biophys Res Commun 508:1264\u20131270. https:\/\/doi.org\/10.1016\/j.bbrc.2018.12.049","journal-title":"Biochem Biophys Res Commun"},{"key":"3687_CR180","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","volume":"317","author":"UK Prospective Diabetes Study Group","year":"1998","unstructured":"UK Prospective Diabetes Study Group, UK Prospective Diabetes Study Group (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 317:703\u2013713","journal-title":"BMJ"},{"key":"3687_CR181","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1080\/02713680701435391","volume":"32","author":"KC Silva","year":"2007","unstructured":"Silva KC, Pinto CC, Biswas SK, Lopes De Faria JB, Lopes De Faria JM (2007) Hypertension increases retinal inflammation in experimental diabetes: a possible mechanism for aggravation of diabetic retinopathy by hypertension. Curr Eye Res 32:533\u2013541. https:\/\/doi.org\/10.1080\/02713680701435391","journal-title":"Curr Eye Res"},{"key":"3687_CR182","doi-asserted-by":"publisher","DOI":"10.3390\/cells13010050","volume":"13","author":"S Malih","year":"2023","unstructured":"Malih S, Song Y-S, Sorenson CM, Sheibani N (2023) Choroidal mast cells and pathophysiology of age-related macular degeneration. Cells 13:50. https:\/\/doi.org\/10.3390\/cells13010050","journal-title":"Cells"},{"key":"3687_CR183","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1136\/bjo.50.8.454","volume":"50","author":"JG Cunha-Vaz","year":"1966","unstructured":"Cunha-Vaz JG (1966) Studies on the permeability of the blood-retinal barrier. Part II. Breakdown of the blood-retinal barrier by injury. Br J Ophthalmol 50:454\u2013462. https:\/\/doi.org\/10.1136\/bjo.50.8.454","journal-title":"Br J Ophthalmol"},{"key":"3687_CR184","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s00125-020-05299-x","volume":"64","author":"H Xie","year":"2021","unstructured":"Xie H, Zhang C, Liu D, Yang Q, Tang L, Wang T, Tian H, Lu L, Xu J-Y, Gao F, Wang J, Jin C, Li W, Xu G, Xu G-T, Zhang J (2021) Erythropoietin protects the inner blood\u2013retinal barrier by inhibiting microglia phagocytosis via Src\/Akt\/cofilin signalling in experimental diabetic retinopathy. Diabetologia 64:211\u2013225. https:\/\/doi.org\/10.1007\/s00125-020-05299-x","journal-title":"Diabetologia"},{"key":"3687_CR185","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190062","volume":"217","author":"CP Profaci","year":"2020","unstructured":"Profaci CP, Munji RN, Pulido RS, Daneman R (2020) The blood\u2013brain barrier in health and disease: important unanswered questions. J Exp Med 217:e20190062. https:\/\/doi.org\/10.1084\/jem.20190062","journal-title":"J Exp Med"},{"key":"3687_CR186","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1002\/ana.23648","volume":"72","author":"R Daneman","year":"2012","unstructured":"Daneman R (2012) The blood\u2013brain barrier in health and disease. Ann Neurol 72:648\u2013672. https:\/\/doi.org\/10.1002\/ana.23648","journal-title":"Ann Neurol"},{"key":"3687_CR187","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2024.1360195","volume":"18","author":"MG Mayer","year":"2024","unstructured":"Mayer MG, Fischer T (2024) Microglia at the blood brain barrier in health and disease. Front Cell Neurosci 18:1360195. https:\/\/doi.org\/10.3389\/fncel.2024.1360195","journal-title":"Front Cell Neurosci"},{"key":"3687_CR188","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1124\/pr.57.2.4","volume":"57","author":"BT Hawkins","year":"2005","unstructured":"Hawkins BT, Davis TP (2005) The blood-brain barrier\/neurovascular unit in health and disease. Pharmacol Rev 57:173\u2013185. https:\/\/doi.org\/10.1124\/pr.57.2.4","journal-title":"Pharmacol Rev"},{"key":"3687_CR189","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2021.108490","volume":"205","author":"M Inada","year":"2021","unstructured":"Inada M, Xu H, Takeuchi M, Ito M, Chen M (2021) Microglia increase tight-junction permeability in coordination with M\u00fcller cells under hypoxic condition in an in vitro model of inner blood-retinal barrier. Exp Eye Res 205:108490. https:\/\/doi.org\/10.1016\/j.exer.2021.108490","journal-title":"Exp Eye Res"},{"key":"3687_CR190","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S1537-1891(02)00200-8","volume":"38","author":"H Wolburg","year":"2002","unstructured":"Wolburg H, Lippoldt A (2002) Tight junctions of the blood\u2013brain barrier. Vasc Pharmacol 38:323\u2013337. https:\/\/doi.org\/10.1016\/S1537-1891(02)00200-8","journal-title":"Vasc Pharmacol"},{"key":"3687_CR191","first-page":"1653","volume":"38","author":"Y Zhang","year":"1997","unstructured":"Zhang Y, Stone J (1997) Role of astrocytes in the control of developing retinal vessels. Invest Ophthalmol Vis Sci 38:1653\u20131666","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3687_CR192","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-022-02643-0","volume":"22","author":"X Zhang","year":"2022","unstructured":"Zhang X, Yu X, Wen Y, Jin L, Zhang L, Zhu H, Zhang D, Xie C, Guo D, Tong J, Shen Y (2022) Functions of retinal astrocytes and M\u00fcller cells in mammalian myopia. BMC Ophthalmol 22:451. https:\/\/doi.org\/10.1186\/s12886-022-02643-0","journal-title":"BMC Ophthalmol"},{"key":"3687_CR193","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.exer.2013.09.014","volume":"116","author":"WM Watkins","year":"2013","unstructured":"Watkins WM, McCollum GW, Savage SR, Capozzi ME, Penn JS, Morrison DG (2013) Hypoxia-induced expression of VEGF splice variants and protein in four retinal cell types. Exp Eye Res 116:240\u2013246. https:\/\/doi.org\/10.1016\/j.exer.2013.09.014","journal-title":"Exp Eye Res"},{"key":"3687_CR194","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2174\/1874364101307010004","volume":"7","author":"N Gupta","year":"2013","unstructured":"Gupta N, Mansoor S, Sharma A, Sapkal A, Sheth J, Falatoonzadeh P, Kuppermann B, Kenney M (2013) Diabetic retinopathy and VEGF. Open Ophthalmol J 7:4\u201310. https:\/\/doi.org\/10.2174\/1874364101307010004","journal-title":"Open Ophthalmol J"},{"key":"3687_CR195","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.exer.2017.10.011","volume":"166","author":"C N\u00fcrnberg","year":"2018","unstructured":"N\u00fcrnberg C, Kociok N, Brockmann C, Lischke T, Crespo-Garcia S, Reichhart N, Wolf S, Baumgrass R, Eming SA, Beer-Hammer S, Joussen AM (2018) Myeloid cells contribute indirectly to VEGF expression upon hypoxia via activation of M\u00fcller cells. Exp Eye Res 166:56\u201369. https:\/\/doi.org\/10.1016\/j.exer.2017.10.011","journal-title":"Exp Eye Res"},{"key":"3687_CR196","doi-asserted-by":"publisher","first-page":"4738","DOI":"10.1523\/JNEUROSCI.15-07-04738.1995","volume":"15","author":"J Stone","year":"1995","unstructured":"Stone J, Itin A, Alon T, Pe\u2019er J, Gnessin H, Chan-Ling T, Keshet E (1995) Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci 15:4738\u20134747. https:\/\/doi.org\/10.1523\/JNEUROSCI.15-07-04738.1995","journal-title":"J Neurosci"},{"key":"3687_CR197","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1677\/jme.1.02008","volume":"37","author":"SX Zhang","year":"2006","unstructured":"Zhang SX, Wang JJ, Gao G, Parke K, Ma J (2006) Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF\u2013VEGF receptor 2 binding in diabetic retinopathy. J Mol Endocrinol 37:1\u201312. https:\/\/doi.org\/10.1677\/jme.1.02008","journal-title":"J Mol Endocrinol"},{"key":"3687_CR198","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/path.2195","volume":"212","author":"C Kaur","year":"2007","unstructured":"Kaur C, Sivakumar V, Yong Z, Lu J, Foulds W, Ling E (2007) Blood\u2013retinal barrier disruption and ultrastructural changes in the hypoxic retina in adult rats: the beneficial effect of melatonin administration. J Pathol 212:429\u2013439. https:\/\/doi.org\/10.1002\/path.2195","journal-title":"J Pathol"},{"key":"3687_CR199","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1167\/iovs.04-0500","volume":"46","author":"TK Stepinac","year":"2005","unstructured":"Stepinac TK, Chamot SR, Rungger-Bra\u00a8ndle E, Ferrez P, Munoz J-L, van den Bergh H, Riva CE, Pournaras CJ, Wagnie`res GA (2005) Light-induced retinal vascular damage by Pd-porphyrin luminescent oxygen probes. Invest Ophthalmol Vis Sci 46:956. https:\/\/doi.org\/10.1167\/iovs.04-0500","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3687_CR200","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1080\/15384101.2022.2087277","volume":"21","author":"K Zhao","year":"2022","unstructured":"Zhao K, Jiang Y, Zhang J, Shi J, Zheng P, Yang C, Chen Y (2022) Celastrol inhibits pathologic neovascularization in oxygen-induced retinopathy by targeting the miR-17-5p\/HIF-1\u03b1\/VEGF pathway. Cell Cycle 21:2091\u20132108. https:\/\/doi.org\/10.1080\/15384101.2022.2087277","journal-title":"Cell Cycle"},{"key":"3687_CR201","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.911430","volume":"16","author":"Y Tao","year":"2022","unstructured":"Tao Y, Murakami Y, Vavvas DG, Sonoda K-H (2022) Necroptosis and neuroinflammation in retinal degeneration. Front Neurosci 16:911430. https:\/\/doi.org\/10.3389\/fnins.2022.911430","journal-title":"Front Neurosci"},{"key":"3687_CR202","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41419-020-02863-6","volume":"11","author":"S Monteiro","year":"2020","unstructured":"Monteiro S, de Ara\u00fajo D, De Logu F, Adembri C, Rizzo S, Janal MN, Landini L, Magi A, Mattei G, Cini N, Pandolfo P, Geppetti P, Nassini R, da Calaza K (2020) TRPA1 mediates damage of the retina induced by ischemia and reperfusion in mice. Cell Death Dis 11:633. https:\/\/doi.org\/10.1038\/s41419-020-02863-6","journal-title":"Cell Death Dis"},{"key":"3687_CR203","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2023.109645","volume":"235","author":"TC Nag","year":"2023","unstructured":"Nag TC (2023) M\u00fcller cell vulnerability in aging human retina: implications on photoreceptor cell survival. Exp Eye Res 235:109645. https:\/\/doi.org\/10.1016\/j.exer.2023.109645","journal-title":"Exp Eye Res"},{"key":"3687_CR204","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2022.109314","volume":"226","author":"M Inoue-Yanagimachi","year":"2023","unstructured":"Inoue-Yanagimachi M, Himori N, Uchida K, Tawarayama H, Sato K, Yamamoto M, Namekata K, Harada T, Nakazawa T (2023) Changes in glial cells and neurotrophic factors due to rotenone-induced oxidative stress in Nrf2 knockout mice. Exp Eye Res 226:109314. https:\/\/doi.org\/10.1016\/j.exer.2022.109314","journal-title":"Exp Eye Res"},{"key":"3687_CR205","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/glia.23739","volume":"68","author":"J Jovanovic","year":"2020","unstructured":"Jovanovic J, Liu X, Kokona D, Zinkernagel MS, Ebneter A (2020) Inhibition of inflammatory cells delays retinal degeneration in experimental retinal vein occlusion in mice. Glia 68:574\u2013588. https:\/\/doi.org\/10.1002\/glia.23739","journal-title":"Glia"},{"key":"3687_CR206","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126859","volume":"10","author":"C Ehlken","year":"2015","unstructured":"Ehlken C, Grundel B, Michels D, Junker B, Stahl A, Schlunck G, Hansen LL, Feltgen N, Martin G, Agostini HT, Pielen A (2015) Increased expression of angiogenic and inflammatory proteins in the vitreous of patients with ischemic central retinal vein occlusion. PLoS One 10:e0126859. https:\/\/doi.org\/10.1371\/journal.pone.0126859","journal-title":"PLoS One"},{"key":"3687_CR207","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.59","volume":"4","author":"J Guadagno","year":"2013","unstructured":"Guadagno J, Xu X, Karajgikar M, Brown A, Cregan SP (2013) Microglia-derived TNF\u03b1 induces apoptosis in neural precursor cells via transcriptional activation of the Bcl-2 family member Puma. Cell Death Dis 4:e538\u2013e538. https:\/\/doi.org\/10.1038\/cddis.2013.59","journal-title":"Cell Death Dis"},{"key":"3687_CR208","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1523\/JNEUROSCI.3575-15.2016","volume":"36","author":"X Wang","year":"2016","unstructured":"Wang X, Zhao L, Zhang J, Fariss RN, Ma W, Kretschmer F, Wang M, Qian H, Badea TC, Diamond JS, Gan W-B, Roger JE, Wong WT (2016) Requirement for microglia for the maintenance of synaptic function and integrity in the mature retina. J Neurosci 36:2827\u20132842. https:\/\/doi.org\/10.1523\/JNEUROSCI.3575-15.2016","journal-title":"J Neurosci"},{"key":"3687_CR209","first-page":"213","volume":"3","author":"JM Provis","year":"1996","unstructured":"Provis JM, Diaz CM, Penfold PL (1996) Microglia in human retina: a heterogeneous population with distinct ontogenies. Perspect Dev Neurobiol 3:213\u2013222","journal-title":"Perspect Dev Neurobiol"},{"key":"3687_CR210","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1167\/iovs.05-1522","volume":"47","author":"D Checchin","year":"2006","unstructured":"Checchin D, Sennlaub F, Levavasseur E, Leduc M, Chemtob S (2006) Potential role of microglia in retinal blood vessel formation. Invest Ophthalmol Vis Sci 47:3595. https:\/\/doi.org\/10.1167\/iovs.05-1522","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3687_CR211","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S0079-6123(08)61151-6","volume":"103","author":"JS Beckman","year":"1994","unstructured":"Beckman JS, Chen J, Crow JP, Ye YZ (1994) Reactions of nitric oxide, superoxide and peroxynitrite with superoxide dismutase in neurodegeneration. Prog Brain Res 103:371\u2013380. https:\/\/doi.org\/10.1016\/S0079-6123(08)61151-6","journal-title":"Prog Brain Res"},{"key":"3687_CR212","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/cdd.2013.109","volume":"21","author":"Y Murakami","year":"2014","unstructured":"Murakami Y, Matsumoto H, Roh M, Giani A, Kataoka K, Morizane Y, Kayama M, Thanos A, Nakatake S, Notomi S, Hisatomi T, Ikeda Y, Ishibashi T, Connor KM, Miller JW, Vavvas DG (2014) Programmed necrosis, not apoptosis, is a key mediator of cell loss and DAMP-mediated inflammation in dsRNA-induced retinal degeneration. Cell Death Differ 21:270\u2013277. https:\/\/doi.org\/10.1038\/cdd.2013.109","journal-title":"Cell Death Differ"},{"key":"3687_CR213","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1167\/iovs.16-20474","volume":"58","author":"A Ebneter","year":"2017","unstructured":"Ebneter A, Kokona D, Schneider N, Zinkernagel MS (2017) Microglia activation and recruitment of circulating macrophages during ischemic experimental branch retinal vein occlusion. Invest Ophthalmol Vis Sci 58:944. https:\/\/doi.org\/10.1167\/iovs.16-20474","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3687_CR214","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02562-3","volume":"19","author":"A Rajesh","year":"2022","unstructured":"Rajesh A, Droho S, Lavine JA (2022) Macrophages in close proximity to the vitreoretinal interface are potential biomarkers of inflammation during retinal vascular disease. J Neuroinflammation 19:203. https:\/\/doi.org\/10.1186\/s12974-022-02562-3","journal-title":"J Neuroinflammation"},{"key":"3687_CR215","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13010045","volume":"13","author":"SM Rangwani","year":"2022","unstructured":"Rangwani SM, Hawn S, Sklar NC, Mirza RG, Lavine JA (2022) Macrophage-like cells are increased in retinal vein occlusion and correlate with more intravitreal injections and worse visual acuity outcomes. JPM 13:45. https:\/\/doi.org\/10.3390\/jpm13010045","journal-title":"JPM"},{"key":"3687_CR216","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.pneurobio.2018.05.006","volume":"173","author":"G Rathnasamy","year":"2019","unstructured":"Rathnasamy G, Foulds WS, Ling E-A, Kaur C (2019) Retinal microglia \u2013 a key player in healthy and diseased retina. Prog Neurobiol 173:18\u201340. https:\/\/doi.org\/10.1016\/j.pneurobio.2018.05.006","journal-title":"Prog Neurobiol"},{"key":"3687_CR217","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11247470","volume":"11","author":"DS Maltsev","year":"2022","unstructured":"Maltsev DS, Kulikov AN, Volkova YV, Burnasheva MA, Vasiliev AS (2022) Retinal macrophage-like cells as a biomarker of inflammation in retinal vein occlusions. JCM 11:7470. https:\/\/doi.org\/10.3390\/jcm11247470","journal-title":"JCM"},{"key":"3687_CR218","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.preteyeres.2017.10.006","volume":"63","author":"A Daruich","year":"2018","unstructured":"Daruich A, Matet A, Moulin A, Kowalczuk L, Nicolas M, Sellam A, Rothschild P-R, Omri S, G\u00e9liz\u00e9 E, Jonet L, Delaunay K, De Kozak Y, Berdugo M, Zhao M, Crisanti P, Behar-Cohen F (2018) Mechanisms of macular edema: beyond the surface. Prog Retin Eye Res 63:20\u201368. https:\/\/doi.org\/10.1016\/j.preteyeres.2017.10.006","journal-title":"Prog Retin Eye Res"},{"key":"3687_CR219","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00296","volume":"3","author":"I Benhar","year":"2012","unstructured":"Benhar I, London A, Schwartz M (2012) The privileged immunity of immune privileged organs: the case of the eye. Front Immunol 3:296. https:\/\/doi.org\/10.3389\/fimmu.2012.00296","journal-title":"Front Immunol"},{"key":"3687_CR220","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.855466","volume":"13","author":"Y Zeng","year":"2022","unstructured":"Zeng Y, Zhang X, Mi L, Gan Y, Su Y, Li M, Yang R, Zhang Y, Wen F (2022) Characterization of macrophage-like cells in retinal vein occlusion using en face optical coherence tomography. Front Immunol 13:855466. https:\/\/doi.org\/10.3389\/fimmu.2022.855466","journal-title":"Front Immunol"},{"key":"3687_CR221","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/705783","volume":"2014","author":"JG Grigsby","year":"2014","unstructured":"Grigsby JG, Cardona SM, Pouw CE, Muniz A, Mendiola AS, Tsin ATC, Allen DM, Cardona AE (2014) The role of microglia in diabetic retinopathy. J Ophthalmol 2014:1\u201315. https:\/\/doi.org\/10.1155\/2014\/705783","journal-title":"J Ophthalmol"},{"key":"3687_CR222","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2015.06.003","volume":"51","author":"E Vecino","year":"2016","unstructured":"Vecino E, Rodriguez FD, Ruzafa N, Pereiro X, Sharma SC (2016) Glia\u2013neuron interactions in the mammalian retina. Prog Retin Eye Res 51:1\u201340. https:\/\/doi.org\/10.1016\/j.preteyeres.2015.06.003","journal-title":"Prog Retin Eye Res"},{"key":"3687_CR223","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1097\/IAE.0b013e3181facfa9","volume":"31","author":"T Sakamoto","year":"2011","unstructured":"Sakamoto T, Ishibashi T (2011) Hyalocytes. Retina 31:222\u2013228. https:\/\/doi.org\/10.1097\/IAE.0b013e3181facfa9","journal-title":"Retina"},{"key":"3687_CR224","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11195636","volume":"11","author":"W Wang","year":"2022","unstructured":"Wang W, Sun G, He L, Chen C (2022) Increased macrophage-like cell density in retinal vein occlusion as characterized by en face optical coherence tomography. J Clin Med 11:5636. https:\/\/doi.org\/10.3390\/jcm11195636","journal-title":"J Clin Med"},{"key":"3687_CR225","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0245763","volume":"16","author":"F Hikage","year":"2021","unstructured":"Hikage F, Furuhashi M, Ida Y, Ohguro H, Watanabe M, Suzuki S, Itoh K (2021) Fatty acid-binding protein 4 is an independent factor in the pathogenesis of retinal vein occlusion. PLoS One 16:e0245763. https:\/\/doi.org\/10.1371\/journal.pone.0245763","journal-title":"PLoS One"},{"key":"3687_CR226","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1096\/fj.09-134882","volume":"23","author":"H Elmasri","year":"2009","unstructured":"Elmasri H, Karaaslan C, Teper Y, Ghelfi E, Weng M, Ince TA, Kozakewich H, Bischoff J, Cataltepe S (2009) Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells. FASEB J 23:3865\u20133873. https:\/\/doi.org\/10.1096\/fj.09-134882","journal-title":"FASEB J"},{"key":"3687_CR227","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering11060584","volume":"11","author":"H Ohguro","year":"2024","unstructured":"Ohguro H, Watanabe M, Sato T, Nishikiori N, Umetsu A, Higashide M, Ogawa T, Furuhashi M (2024) FABP4 is an indispensable factor for regulating cellular metabolic functions of the human retinal choroid. Bioengineering 11:584. https:\/\/doi.org\/10.3390\/bioengineering11060584","journal-title":"Bioengineering"},{"key":"3687_CR228","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.2174\/0929867325666181008154622","volume":"27","author":"M Shi","year":"2020","unstructured":"Shi M, Ma L, Fu P (2020) Role of fatty acid binding protein 4 (FABP4) in kidney disease. CMC 27:3657\u20133664. https:\/\/doi.org\/10.2174\/0929867325666181008154622","journal-title":"CMC"},{"key":"3687_CR229","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1111\/jdi.12982","volume":"10","author":"M Furuhashi","year":"2019","unstructured":"Furuhashi M, Matsumoto M, Murase T, Nakamura T, Higashiura Y, Koyama M, Tanaka M, Moniwa N, Ohnishi H, Saitoh S, Shimamoto K, Miura T (2019) Independent links between plasma xanthine oxidoreductase activity and levels of adipokines. J Diabetes Invest 10:1059\u20131067. https:\/\/doi.org\/10.1111\/jdi.12982","journal-title":"J Diabetes Invest"},{"key":"3687_CR230","doi-asserted-by":"publisher","first-page":"216","DOI":"10.5551\/jat.48710","volume":"26","author":"M Furuhashi","year":"2019","unstructured":"Furuhashi M (2019) Fatty acid-binding protein 4 in cardiovascular and metabolic diseases. J Atheroscler Thromb 26:216\u2013232. https:\/\/doi.org\/10.5551\/jat.48710","journal-title":"J Atheroscler Thromb"},{"key":"3687_CR231","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nrendo.2015.122","volume":"11","author":"GS Hotamisligil","year":"2015","unstructured":"Hotamisligil GS, Bernlohr DA (2015) Metabolic functions of FABPs\u2014mechanisms and therapeutic implications. Nat Rev Endocrinol 11:592\u2013605. https:\/\/doi.org\/10.1038\/nrendo.2015.122","journal-title":"Nat Rev Endocrinol"},{"key":"3687_CR232","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00441-009-0862-2","volume":"338","author":"S Saino-Saito","year":"2009","unstructured":"Saino-Saito S, Nourani RM, Iwasa H, Kondo H, Owada Y (2009) Discrete localization of various fatty-acid-binding proteins in various cell populations of mouse retina. Cell Tissue Res 338:191\u2013201. https:\/\/doi.org\/10.1007\/s00441-009-0862-2","journal-title":"Cell Tissue Res"},{"key":"3687_CR233","doi-asserted-by":"publisher","first-page":"9322","DOI":"10.18632\/oncotarget.6975","volume":"7","author":"FS Forootan","year":"2016","unstructured":"Forootan FS, Forootan SS, Gou X, Yang J, Liu B, Chen D, Fayi MSA, Al-Jameel W, Rudland PS, Hussain SA, Ke Y (2016) Fatty acid activated PPAR\u03b3 promotes tumorigenicity of prostate cancer cells by up regulating VEGF via PPAR responsive elements of the promoter. Oncotarget 7:9322\u20139339. https:\/\/doi.org\/10.18632\/oncotarget.6975","journal-title":"Oncotarget"},{"key":"3687_CR234","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-91857-1","volume":"11","author":"K Itoh","year":"2021","unstructured":"Itoh K, Furuhashi M, Ida Y, Ohguro H, Watanabe M, Suzuki S, Hikage F (2021) Detection of significantly high vitreous concentrations of fatty acid-binding protein 4 in patients with proliferative diabetic retinopathy. Sci Rep 11:12382. https:\/\/doi.org\/10.1038\/s41598-021-91857-1","journal-title":"Sci Rep"},{"key":"3687_CR235","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00395-024-01032-6","volume":"119","author":"D Fraccarollo","year":"2024","unstructured":"Fraccarollo D, Geffers R, Galuppo P, Bauersachs J (2024) Mineralocorticoid receptor promotes cardiac macrophage inflammaging. Basic Res Cardiol 119:243\u2013260. https:\/\/doi.org\/10.1007\/s00395-024-01032-6","journal-title":"Basic Res Cardiol"},{"key":"3687_CR236","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.diabet.2019.04.002","volume":"45","author":"F Semeraro","year":"2019","unstructured":"Semeraro F, Morescalchi F, Cancarini A, Russo A, Rezzola S, Costagliola C (2019) Diabetic retinopathy, a vascular and inflammatory disease: therapeutic implications. Diabetes Metab 45:517\u2013527. https:\/\/doi.org\/10.1016\/j.diabet.2019.04.002","journal-title":"Diabetes Metab"},{"key":"3687_CR237","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.2337\/diacare.26.9.2653","volume":"26","author":"TA Ciulla","year":"2003","unstructured":"Ciulla TA, Amador AG, Zinman B (2003) Diabetic retinopathy and diabetic macular edema. Diabetes Care 26:2653\u20132664. https:\/\/doi.org\/10.2337\/diacare.26.9.2653","journal-title":"Diabetes Care"},{"key":"3687_CR238","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1167\/tvst.6.2.7","volume":"6","author":"MJ Allingham","year":"2017","unstructured":"Allingham MJ, Mukherjee D, Lally EB, Rabbani H, Mettu PS, Cousins SW, Farsiu S (2017) A quantitative approach to predict differential effects of anti-VEGF treatment on diffuse and focal leakage in patients with diabetic macular edema: a pilot study. Transl Vis Sci Technol 6:7. https:\/\/doi.org\/10.1167\/tvst.6.2.7","journal-title":"Transl Vis Sci Technol"},{"key":"3687_CR239","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008158","volume":"4","author":"T Yoshimura","year":"2009","unstructured":"Yoshimura T, Sonoda K-H, Sugahara M, Mochizuki Y, Enaida H, Oshima Y, Ueno A, Hata Y, Yoshida H, Ishibashi T (2009) Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases. PLoS One 4:e8158. https:\/\/doi.org\/10.1371\/journal.pone.0008158","journal-title":"PLoS One"},{"key":"3687_CR240","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0127567","volume":"10","author":"JM Skeie","year":"2015","unstructured":"Skeie JM, Roybal CN, Mahajan VB (2015) Proteomic insight into the molecular function of the vitreous. PLoS One 10:e0127567. https:\/\/doi.org\/10.1371\/journal.pone.0127567","journal-title":"PLoS One"},{"key":"3687_CR241","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/jlb.63.1.108","volume":"63","author":"MN Ajuebor","year":"1998","unstructured":"Ajuebor MN, Flower RJ, Hannon R, Christie M, Bowers K, Verity A, Perretti M (1998) Endogenous monocyte chemoattractant protein-1 recruits monocytes in the zymosan peritonitis model. J Leukoc Biol 63:108\u2013116. https:\/\/doi.org\/10.1002\/jlb.63.1.108","journal-title":"J Leukoc Biol"},{"key":"3687_CR242","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3389\/fneur.2015.00081","volume":"6","author":"S Fumagalli","year":"2015","unstructured":"Fumagalli S, Perego C, Pischiutta F, Zanier ER, De Simoni M-G (2015) The ischemic environment drives microglia and macrophage function. Front Neurol 6:81. https:\/\/doi.org\/10.3389\/fneur.2015.00081","journal-title":"Front Neurol"},{"key":"3687_CR243","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/glia.24501","volume":"72","author":"AM Planas","year":"2024","unstructured":"Planas AM (2024) Role of microglia in stroke. Glia 72:1016\u20131053. https:\/\/doi.org\/10.1002\/glia.24501","journal-title":"Glia"},{"key":"3687_CR244","doi-asserted-by":"publisher","first-page":"3846","DOI":"10.3390\/ijms19123846","volume":"19","author":"E Alizadeh","year":"2018","unstructured":"Alizadeh E, Mammadzada P, Andr\u00e9 H (2018) The different facades of retinal and choroidal endothelial cells in response to hypoxia. Int J Mol Sci 19:3846. https:\/\/doi.org\/10.3390\/ijms19123846","journal-title":"Int J Mol Sci"},{"key":"3687_CR245","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00417-004-0874-2","volume":"242","author":"S Yoshida","year":"2004","unstructured":"Yoshida S, Yoshida A, Ishibashi T (2004) Induction of IL-8, MCP-1, and bFGF by TNF-\u03b1 in retinal glial cells: implications for retinal neovascularization during post-ischemic inflammation. Graefes Arch Clin Exp Ophthalmol 242:409\u2013413. https:\/\/doi.org\/10.1007\/s00417-004-0874-2","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3687_CR246","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.bbadis.2010.12.014","volume":"1822","author":"TC Theoharides","year":"2012","unstructured":"Theoharides TC, Alysandratos K-D, Angelidou A, Delivanis D-A, Sismanopoulos N, Zhang B, Asadi S, Vasiadi M, Weng Z, Miniati A, Kalogeromitros D (2012) Mast cells and inflammation. Biochimica et Biophys Acta (BBA) Mol Basis Dis 1822:21\u201333. https:\/\/doi.org\/10.1016\/j.bbadis.2010.12.014","journal-title":"Biochimica et Biophys Acta (BBA) Mol Basis Dis"},{"key":"3687_CR247","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1172\/JCI89893","volume":"127","author":"K Matsuda","year":"2017","unstructured":"Matsuda K, Okamoto N, Kondo M, Arkwright PD, Karasawa K, Ishizaka S, Yokota S, Matsuda A, Jung K, Oida K, Amagai Y, Jang H, Noda E, Kakinuma R, Yasui K, Kaku U, Mori Y, Onai N, Ohteki T, Tanaka A, Matsuda H (2017) Mast cell hyperactivity underpins the development of oxygen-induced retinopathy. J Clin Invest 127:3987\u20134000. https:\/\/doi.org\/10.1172\/JCI89893","journal-title":"J Clin Invest"},{"key":"3687_CR248","doi-asserted-by":"publisher","first-page":"10117","DOI":"10.1096\/fj.202000807R","volume":"34","author":"S Ogura","year":"2020","unstructured":"Ogura S, Baldeosingh R, Bhutto IA, Kambhampati SP, Scott McLeod D, Edwards MM, Rais R, Schubert W, Lutty GA (2020) A role for mast cells in geographic atrophy. FASEB J 34:10117\u201310131. https:\/\/doi.org\/10.1096\/fj.202000807R","journal-title":"FASEB J"},{"key":"3687_CR249","doi-asserted-by":"publisher","DOI":"10.3390\/cells11203329","volume":"11","author":"IS Zaitoun","year":"2022","unstructured":"Zaitoun IS, Song Y-S, Zaitoun HB, Sorenson CM, Sheibani N (2022) Assessment of choroidal vasculature and innate immune cells in the eyes of albino and pigmented mice. Cells 11:3329. https:\/\/doi.org\/10.3390\/cells11203329","journal-title":"Cells"},{"key":"3687_CR250","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.preteyeres.2017.03.002","volume":"60","author":"S Datta","year":"2017","unstructured":"Datta S, Cano M, Ebrahimi K, Wang L, Handa JT (2017) The impact of oxidative stress and inflammation on RPE degeneration in non-neovascular AMD. Prog Retin Eye Res 60:201\u2013218. https:\/\/doi.org\/10.1016\/j.preteyeres.2017.03.002","journal-title":"Prog Retin Eye Res"},{"key":"3687_CR251","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2118510119","volume":"119","author":"S Mcharg","year":"2022","unstructured":"Mcharg S, Booth L, Perveen R, Riba Garcia I, Brace N, Bayatti N, Sergouniotis PI, Phillips AM, Day AJ, Black GCM, Clark SJ, Dowsey AW, Unwin RD, Bishop PN (2022) Mast cell infiltration of the choroid and protease release are early events in age-related macular degeneration associated with genetic risk at both chromosomes 1q32 and 10q26. Proc Natl Acad Sci U S A 119:e2118510119. https:\/\/doi.org\/10.1073\/pnas.2118510119","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3687_CR252","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41433-021-01725-5","volume":"36","author":"AJ Clare","year":"2022","unstructured":"Clare AJ, Liu J, Copland DA, Theodoropoulou S, Dick AD (2022) Unravelling the therapeutic potential of IL-33 for atrophic AMD. Eye 36:266\u2013272. https:\/\/doi.org\/10.1038\/s41433-021-01725-5","journal-title":"Eye"},{"key":"3687_CR253","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s10792-024-03158-x","volume":"44","author":"L Meng","year":"2024","unstructured":"Meng L, Yang M, Jiang X, Li Y, Han X (2024) Comparing ranibizumab, dexamethasone implant, and combined therapy for macular edema secondary to branch retinal vein occlusion: a clinical trial. Int Ophthalmol 44:262. https:\/\/doi.org\/10.1007\/s10792-024-03158-x","journal-title":"Int Ophthalmol"},{"key":"3687_CR254","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41433-024-03544-w","volume":"39","author":"P Forte","year":"2025","unstructured":"Forte P, Feo A, Sarraf D, Romano MR, Nicol\u00f2 M (2025) Current insights and challenges in the management of perifoveal vascular anomalous complex (PVAC): a systematic review of multimodal imaging features and treatment strategies. Eye 39:449\u2013459. https:\/\/doi.org\/10.1038\/s41433-024-03544-w","journal-title":"Eye"},{"key":"3687_CR255","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1007\/s12325-017-0559-y","volume":"34","author":"P Scholz","year":"2017","unstructured":"Scholz P, Altay L, Fauser S (2017) A review of subthreshold micropulse laser for treatment of macular disorders. Adv Ther 34:1528\u20131555. https:\/\/doi.org\/10.1007\/s12325-017-0559-y","journal-title":"Adv Ther"},{"key":"3687_CR256","doi-asserted-by":"publisher","first-page":"5300","DOI":"10.3390\/jcm10225300","volume":"10","author":"A Grzybowski","year":"2021","unstructured":"Grzybowski A, Markeviciute A, Zemaitiene R (2021) Treatment of macular edema in vascular retinal diseases: a 2021 update. J Clin Med 10:5300. https:\/\/doi.org\/10.3390\/jcm10225300","journal-title":"J Clin Med"},{"key":"3687_CR257","doi-asserted-by":"publisher","first-page":"887","DOI":"10.2147\/OPTH.S513141","volume":"19","author":"Q Zhu","year":"2025","unstructured":"Zhu Q, Pan X, Du Z, Ying J, Hu Y, Yi Q, Fu X (2025) From monotherapy to combination strategies: redefining treatment approaches for multiple-cause macular edema. Clin Ophthalmol 19:887\u2013897. https:\/\/doi.org\/10.2147\/OPTH.S513141","journal-title":"Clin Ophthalmol"},{"key":"3687_CR258","doi-asserted-by":"publisher","first-page":"e939277","DOI":"10.12659\/MSM.939277","volume":"29","author":"F Ren","year":"2023","unstructured":"Ren F, Gong H, Zhang H, Zhang X, Liu X, Gao P, Li J, Zhang G (2023) Combination therapy using anti-vascular endothelial growth factor (vegf) drugs and steroids for macular edema in retinal vein occlusions. Med Sci Monit 29:e939277. https:\/\/doi.org\/10.12659\/MSM.939277","journal-title":"Med Sci Monit"},{"key":"3687_CR259","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.1177\/11206721211073402","volume":"32","author":"G Scondotto","year":"2022","unstructured":"Scondotto G, Sultana J, Vadal\u00e0 M, Avitabile T, Cillino S, Foti SS, Labbate L, Longo A, Mirabelli E, Puzo MR, Rapisarda C, Ibanez Toro P, Trombetta CJ, Trifir\u00f2 G, Virgili G (2022) Assessment of intravitreal anti-VEGF drugs and dexamethasone for retinal diseases in real world setting: A multi-centre prospective study from Southern Italy. Eur J Ophthalmol 32:3064\u20133073. https:\/\/doi.org\/10.1177\/11206721211073402","journal-title":"Eur J Ophthalmol"},{"key":"3687_CR260","doi-asserted-by":"publisher","first-page":"e309","DOI":"10.1111\/aos.14248","volume":"98","author":"Q Yi","year":"2020","unstructured":"Yi Q, Wang Y, Chen L, Li W, Shen Y, Jin Y, Yang J, Wang Y, Yuan J, Cheng L (2020) Implication of inflammatory cytokines in the aqueous humour for management of macular diseases. Acta Ophthalmol 98:e309\u2013e315. https:\/\/doi.org\/10.1111\/aos.14248","journal-title":"Acta Ophthalmol"},{"key":"3687_CR261","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1007\/s00417-025-06738-4","volume":"263","author":"Y Arai","year":"2025","unstructured":"Arai Y, Takahashi H, Inoda S, Sakamoto S, Kawashima H, Yanagi Y (2025) Effectiveness and cytokine profile of combined anti-vascular endothelial growth factor and corticosteroid therapy for chronic retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 263:1427\u20131434. https:\/\/doi.org\/10.1007\/s00417-025-06738-4","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3687_CR262","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.ophtha.2024.01.029","volume":"131","author":"R Tadayoni","year":"2024","unstructured":"Tadayoni R, Paris LP, Danzig CJ, Abreu F, Khanani AM, Brittain C, Lai TYY, Haskova Z, Sakamoto T, Kotecha A, Schlottmann PG, Liu Y, Seres A, Retiere A-C, Willis JR, Yoon YH (2024) Efficacy and safety of faricimab for macular edema due to retinal vein occlusion. Ophthalmology 131:950\u2013960. https:\/\/doi.org\/10.1016\/j.ophtha.2024.01.029","journal-title":"Ophthalmology"},{"key":"3687_CR263","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/IAE.0000000000003632","volume":"43","author":"MA Singer","year":"2023","unstructured":"Singer MA, Boyer DS, Williams S, McKee H, Kerr K, Pegoraro T, Trevino L, Kopczynski CC, Hollander DA (2023) Phase 2 randomized study (orion-1) of a novel, biodegradable dexamethasone implant (ar-1105) for the treatment of macular edema due to central or branch retinal vein occlusion. Retina 43:25\u201333. https:\/\/doi.org\/10.1097\/IAE.0000000000003632","journal-title":"Retina"},{"key":"3687_CR264","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.2147\/OPTH.S231801","volume":"15","author":"AM Khanani","year":"2021","unstructured":"Khanani AM, Russell MW, Aziz AA, Danzig CJ, Weng CY, Eichenbaum DA, Singh RP (2021) Angiopoietins as potential targets in management of retinal disease. Clin Ophthalmol 15:3747\u20133755. https:\/\/doi.org\/10.2147\/OPTH.S231801","journal-title":"Clin Ophthalmol"},{"key":"3687_CR265","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1080\/13543784.2022.2052042","volume":"31","author":"HD Stern","year":"2022","unstructured":"Stern HD, Hussain RM (2022) KSI-301: an investigational anti-VEGF biopolymer conjugate for retinal diseases. Exp Opin Investig Drugs 31:443\u2013449. https:\/\/doi.org\/10.1080\/13543784.2022.2052042","journal-title":"Exp Opin Investig Drugs"},{"key":"3687_CR266","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1080\/17512433.2023.2277882","volume":"16","author":"M Driban","year":"2023","unstructured":"Driban M, Kedia N, Arora S, Chhablani J (2023) Novel pharmaceuticals for the management of retinal vein occlusion and linked disorders. Exp Rev Clin Pharmacol 16:1125\u20131139. https:\/\/doi.org\/10.1080\/17512433.2023.2277882","journal-title":"Exp Rev Clin Pharmacol"},{"key":"3687_CR267","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40360-025-00866-7","volume":"26","author":"C Zhao","year":"2025","unstructured":"Zhao C, Lan L, Shi X, Li J, Fan S (2025) Assessment the real-world safety of intravitreal dexamethasone implant (Ozurdex): novel insights from a comprehensive pharmacovigilance analysis utilizing the FAERS database. BMC Pharmacol Toxicol 26:29. https:\/\/doi.org\/10.1186\/s40360-025-00866-7","journal-title":"BMC Pharmacol Toxicol"},{"key":"3687_CR268","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1159\/000527447","volume":"66","author":"M Zhang","year":"2023","unstructured":"Zhang M, Liu Y, Song M, Yu Y, Ruan S, Zheng K, Wang F, Sun X (2023) Intravitreal Dexamethasone Implant Has Better Retinal Perfusion than Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Retinal Vein Occlusion: A Five-Year Real-World Study. Ophthalmic Res 66:247\u2013258. https:\/\/doi.org\/10.1159\/000527447","journal-title":"Ophthalmic Res"},{"key":"3687_CR269","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12886-023-02808-5","volume":"23","author":"BM Ali","year":"2023","unstructured":"Ali BM, Azmeh AM, Alhalabi NM (2023) Suprachoroidal triamcinolone acetonide for the treatment of macular edema associated with retinal vein occlusion: a pilot study. BMC Ophthalmol 23:60. https:\/\/doi.org\/10.1186\/s12886-023-02808-5","journal-title":"BMC Ophthalmol"},{"key":"3687_CR270","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1007\/s12325-024-02937-3","volume":"41","author":"Y Lee","year":"2024","unstructured":"Lee Y, Zalewski D, Oleksy P, Wyl\u0119ga\u0142a E, Orski M, Lee J, Kim S (2024) Usability of the SB11 Pre-filled Syringe (PFS) in Patients with Retinal Diseases. Adv Ther 41:3426\u20133436. https:\/\/doi.org\/10.1007\/s12325-024-02937-3","journal-title":"Adv Ther"},{"key":"3687_CR271","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/jbm.a.37626","volume":"112","author":"L Teng","year":"2024","unstructured":"Teng L, Sun Y, Teng S, Hui P (2024) Applications of nanomaterials in anti-VEGF treatment for ophthalmic diseases. J Biomed Mater Res 112:296\u2013306. https:\/\/doi.org\/10.1002\/jbm.a.37626","journal-title":"J Biomed Mater Res"},{"key":"3687_CR272","doi-asserted-by":"publisher","first-page":"7728","DOI":"10.1021\/acsnano.4c12327","volume":"19","author":"S Wang","year":"2025","unstructured":"Wang S, Chen X, Liu Y, Jiang Y, Li J, Ren L, Wang J, Wang Z, Li Y, Wu H, Zhang Y, Gao Y, Wang L (2025) Hybrid biomembrane-functionalized nanorobots penetrate the vitreous body of the eye for the treatment of retinal vein occlusion. ACS Nano 19:7728\u20137741. https:\/\/doi.org\/10.1021\/acsnano.4c12327","journal-title":"ACS Nano"},{"key":"3687_CR273","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1186\/s40001-024-02166-y","volume":"29","author":"S Qin","year":"2024","unstructured":"Qin S, Cao G, Tang M, Sun S, Dong L (2024) Baicalin alleviates the injury of human retinal pigment epithelium cells and improves branch retinal vein occlusion in rats by inhibiting the HIF-1\u03b1\/VEGFA axis. Eur J Med Res 29:564. https:\/\/doi.org\/10.1186\/s40001-024-02166-y","journal-title":"Eur J Med Res"},{"key":"3687_CR274","doi-asserted-by":"publisher","first-page":"13622","DOI":"10.1080\/21655979.2022.2081755","volume":"13","author":"L Kong","year":"2022","unstructured":"Kong L, Li J, Yang Y, Tang H, Zou H (2022) Paeoniflorin alleviates the progression of retinal vein occlusion via inhibiting hypoxia inducible factor-1\u03b1\/vascular endothelial growth factor\/STAT3 pathway. Bioengineered 13:13622\u201313631. https:\/\/doi.org\/10.1080\/21655979.2022.2081755","journal-title":"Bioengineered"},{"key":"3687_CR275","doi-asserted-by":"publisher","first-page":"8048","DOI":"10.1038\/s41598-024-58734-z","volume":"14","author":"J Li","year":"2024","unstructured":"Li J, Guo Z, Wu J (2024) Investigation into safflower injection as a prophylactic treatment for retinal vein occlusion in a rabbit model. Sci Rep 14:8048. https:\/\/doi.org\/10.1038\/s41598-024-58734-z","journal-title":"Sci Rep"},{"key":"3687_CR276","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2023.109405","volume":"228","author":"A Nishinaka","year":"2023","unstructured":"Nishinaka A, Tanaka M, Ohara K, Sugaru E, Shishido Y, Sugiura A, Moriguchi Y, Toui A, Nakamura S, Shimada K, Watanabe S, Hara H, Shimazawa M (2023) TRPV4 channels promote vascular permeability in retinal vascular disease. Exp Eye Res 228:109405. https:\/\/doi.org\/10.1016\/j.exer.2023.109405","journal-title":"Exp Eye Res"},{"key":"3687_CR277","doi-asserted-by":"publisher","first-page":"9208489","DOI":"10.1155\/2017\/9208489","volume":"2017","author":"T Masuda","year":"2017","unstructured":"Masuda T, Shimazawa M, Hara H (2017) Retinal diseases associated with oxidative stress and the effects of a free radical scavenger (Edaravone). Oxid Med Cell Longev 2017:9208489. https:\/\/doi.org\/10.1155\/2017\/9208489","journal-title":"Oxid Med Cell Longev"},{"key":"3687_CR278","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1055\/s-0044-1791232","volume":"125","author":"EW B\u00f6hm","year":"2025","unstructured":"B\u00f6hm EW, Buonfiglio F, Korb CA, Dauth A, Pfeiffer N, Br\u0119borowicz A, Gericke A (2025) Potential of sulodexide in the treatment of diabetic retinopathy and retinal vein occlusion. Thromb Haemost 125:291\u2013307. https:\/\/doi.org\/10.1055\/s-0044-1791232","journal-title":"Thromb Haemost"},{"key":"3687_CR279","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1167\/iovs.65.6.19","volume":"65","author":"H-R Tsai","year":"2024","unstructured":"Tsai H-R, Lin Y-J, Yeh J-I, Lin S-M, Liu PP-S, Chang Y-C, Lee Y-C, Loh C-H, Huang H-K (2024) Use of sodium-glucose co-transporter 2 inhibitors in patients with type 2 diabetes and the incidence of retinal vein occlusion in Taiwan. Invest Ophthalmol Vis Sci 65:19. https:\/\/doi.org\/10.1167\/iovs.65.6.19","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3687_CR280","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2024.110168","volume":"250","author":"F Chen","year":"2025","unstructured":"Chen F, Wang Q, Li Y, Li F, Zhang L, Gu X (2025) TGF-\u03b21-induced apoptosis in retinal endothelial cells is implicated in retinal vein occlusion. Exp Eye Res 250:110168. https:\/\/doi.org\/10.1016\/j.exer.2024.110168","journal-title":"Exp Eye Res"},{"key":"3687_CR281","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2025.177293","volume":"991","author":"D Yu","year":"2025","unstructured":"Yu D, Rong H, Xing D, Hu L, Wen Y, Wang X, Zhang W, Fan H, Zhao Y, Gong X, Chen L, Ma X, Li Z (2025) Thrombolytic efficacy and safety of recombinant scu-PA in a rabbit retinal vein occlusion model. Eur J Pharmacol 991:177293. https:\/\/doi.org\/10.1016\/j.ejphar.2025.177293","journal-title":"Eur J Pharmacol"},{"key":"3687_CR282","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1167\/iovs.66.5.2","volume":"66","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, Ge Z, Guo T, Liu H, Zhou Y, Chen J, Xu H, Chen Z (2025) Complement C3\/C3aR signaling pathway inhibition ameliorates retinal damage in experimental retinal vein occlusion. Invest Ophthalmol Vis Sci 66:2. https:\/\/doi.org\/10.1167\/iovs.66.5.2","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3687_CR283","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1007\/s00417-021-05072-9","volume":"259","author":"C Hara","year":"2021","unstructured":"Hara C, Kamei M, Sakaguchi H, Matsumura N, Sakimoto S, Suzuki M, Nishida K, Fukushima Y, Nishida K (2021) Long-term outcomes of intravitreal activated protein C injection for ischemic central retinal vein occlusion: an extension trial. Graefes Arch Clin Exp Ophthalmol 259:2919\u20132927. https:\/\/doi.org\/10.1007\/s00417-021-05072-9","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3687_CR284","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s13063-024-08082-0","volume":"25","author":"B Yao","year":"2024","unstructured":"Yao B, Wang B, Yang J, Geng Y, Yu H, Liu Y, Liu G, Wang X (2024) Clinical effects of atorvastatin combined with conbercept in the treatment of patients with macular edema secondary to retinal vein occlusion and carotid plaque: study protocol for a prospective randomized controlled trial. Trials 25:244. https:\/\/doi.org\/10.1186\/s13063-024-08082-0","journal-title":"Trials"},{"key":"3687_CR285","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1038\/s41467-020-16902-5","volume":"11","author":"MI Avrutsky","year":"2020","unstructured":"Avrutsky MI, Ortiz CC, Johnson KV, Potenski AM, Chen CW, Lawson JM, White AJ, Yuen SK, Morales FN, Canepa E, Snipas S, Salvesen GS, Jean YY, Troy CM (2020) Endothelial activation of caspase-9 promotes neurovascular injury in retinal vein occlusion. Nat Commun 11:3173. https:\/\/doi.org\/10.1038\/s41467-020-16902-5","journal-title":"Nat Commun"},{"key":"3687_CR286","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/qjmed\/hcab328","volume":"115","author":"C-C Hsieh","year":"2022","unstructured":"Hsieh C-C, Lee W-JA (2022) Hyperbaric oxygen therapy for combined branch retinal artery and branch retinal vein occlusion. QJM 115:259\u2013260. https:\/\/doi.org\/10.1093\/qjmed\/hcab328","journal-title":"QJM"},{"key":"3687_CR287","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2450\/2022.0276-21","volume":"20","author":"F Paciullo","year":"2022","unstructured":"Paciullo F, Valeriani E, Porfidia A, Di Nisio M, Donadini MP, Marcucci R, Prisco D, Cagini C, Gresele P, Ageno W (2022) Antithrombotic treatment of retinal vein occlusion: a position statement from the Italian Society on Thrombosis and Haemostasis (SISET). Blood Transfus 20:341\u2013347. https:\/\/doi.org\/10.2450\/2022.0276-21","journal-title":"Blood Transfus"},{"key":"3687_CR288","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12886-019-1105-2","volume":"19","author":"P Long","year":"2019","unstructured":"Long P, Yan W, He M, Zhang Q, Wang Z, Li M, Xue J, Chen T, An J, Zhang Z (2019) Protective effects of hydrogen gas in a rat model of branch retinal vein occlusion via decreasing VEGF-\u03b1 expression. BMC Ophthalmol 19:112. https:\/\/doi.org\/10.1186\/s12886-019-1105-2","journal-title":"BMC Ophthalmol"},{"key":"3687_CR289","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1167\/iovs.66.4.74","volume":"66","author":"B Chen","year":"2025","unstructured":"Chen B, Qiu J, Meng Y, Liang Y, Liu D, Hu Y, Meng Z, Luo J (2025) Radiomics analysis based on optical coherence tomography to prognose the efficacy of Anti-VEGF therapy of retinal vein occlusion-related macular edema. Invest Ophthalmol Vis Sci 66:74. https:\/\/doi.org\/10.1167\/iovs.66.4.74","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3687_CR290","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10916-025-02190-3","volume":"49","author":"C Liang","year":"2025","unstructured":"Liang C, Liu L, Zhao T, Ouyang W, Yu G, Lyu J, Zhong J (2025) Predicting visual acuity after retinal vein occlusion anti-vegf treatment: development and validation of an interpretable machine learning model. J Med Syst 49:57. https:\/\/doi.org\/10.1007\/s10916-025-02190-3","journal-title":"J Med Syst"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-025-03687-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-025-03687-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-025-03687-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T18:05:01Z","timestamp":1766167501000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-025-03687-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":290,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3687"],"URL":"https:\/\/doi.org\/10.1007\/s10792-025-03687-z","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,28]]},"assertion":[{"value":"22 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"358"}}